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ABSTRACT 
 
Modeling Toxic Endpoints for Improving Human Health Risk Assessment.  (May 2007) 
Erica Dawn Bruce, B.S., Texas A&M University; 
 
M.S., Texas A&M University 
 
Chair of Advisory Committee:  Dr. Robin L. Autenrieth 
 
 
 Risk assessment procedures for mixtures of polycyclic aromatic hydrocarbons 
(PAHs) present a problem due to the lack of available potency and toxicity data on 
mixtures and individual compounds.  This study examines the toxicity of parent 
compound PAHs and binary mixtures of PAHs in order to bridge the gap between 
component assessment and mixture assessment.  Seven pure parent compound PAHs and 
four binary mixtures of PAHs were examined in the Salmonella/Microsome 
Mutagenicity Assay, a Gap Junction Intercellular Communication (GJIC) assay and the 
7-ethoxyresorufin-O-deethylase assay (EROD).  These assays were chosen for their 
ability to measure specific toxic endpoints related to the carcinogenic process (i.e. 
initiation, promotion, progression).  Data from these assays was used in further studies to 
build Quantitative Structure-Activity Relationships (QSARs) to estimate toxic endpoints 
and to test the additive assumption in PAH mixtures.  These QSAR models will allow 
for the development of bioassay based potential potencies (PPB) or toxic equivalency 
factors (TEFs) that are derived not only from bioassay data, but also from structure, 
activity, and physical/chemical properties.  These models can be extended to any 
environmental media to evaluate risk to human health from exposures to PAHs. 
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CHAPTER I   
 
INTRODUCTION 
 
 
 
The Comprehensive Environmental Response, Compensation, and Liability Act 
(CERCLA) provides federal authority for the remediation of hazardous waste sites 
deemed severe by the U.S. Environmental Protection Agency’s (USEPA) National 
Priority List (NPL) (USEPA, 2006a, 2006b).  Currently 1245 hazardous waste sites are 
on the NPL and pose a risk to human health and the environment.  The contaminants on 
these sites have a potential to cause harm to those exposed and therefore an assessment 
of the potential hazards must be made.  The USEPA guidelines are the industry standard 
when performing environmental and human health risk assessment (Sims, P. et al., 
1974).  There are four major steps in this framework, (1) data collection and evaluation, 
(2) exposure assessment, (3) toxicity assessment, and (4) risk characterization.   
There are two basic approaches that the EPA gives guidance for when doing risk 
assessments of complex mixtures, a whole mixture approach and a component approach 
(USEPA, 1986, 1993, 2000).  These two methods are based on the nature and quality of 
the available data and the assumption that chemical toxicity among the PAHs in a 
mixture is additive.  An additive response occurs when the combined response or two 
chemicals is equal to the sum of the two chemicals individually.  PAHs in mixtures can 
also have a synergistic or inhibitory response.   
_____________________________________ 
The style and format of this dissertation follows that of the Journal of Toxicology and 
Environmental Health – Part B. 
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Synergistic responses occur when the combined effect of two chemicals are much 
greater than the sum of the two chemical individually.  While an inhibitory response 
occurs when two chemicals interfere with one another’s actions or one chemical 
interferes with the other chemical.   
Among environmental health scientists, the consensus is that current data will only 
support a quantitative risk assessment for the carcinogenic effects of PAHs (Schoeny, R. 
et al., 1998).  There are three approaches that are commonly used for evaluating the 
human health risks associated with the exposure to PAH containing mixtures: the 
surrogate mixture approach, the comparative potency approach, and the relative potency 
factor approach.   
The surrogate mixture approach is a mixture-based approach that should only be 
used to estimate the potency of the PAH component of the mixture of concern because 
benzo (a) pyrene (BAP) is not a consistent indicator of the concentration of “non-PAH” 
components of a mixture (Versar et al., 2002).  An inherent assumption with this method 
is that any PAH mixture is a dilution of a “surrogate” PAH mixture, where the surrogate 
mixture is characterized chemically and toxicologically.  The assumption that there is 
“sufficient similarity” both chemically and toxicologically between the mixture of 
concern and the surrogate mixture can be problematic if the mixture is not well 
characterized or sufficiency is questionable.  A second assumption is that the factor used 
to measure the extent of dilution of the mixture of concern (i.e. the BAP concentration) 
is a valid indicator of the concentration of all PAHs in the mixture and will influence the 
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carcinogenic potential.  The assumptions that are required to use this method lead to 
some specific advantages and disadvantages. 
An advantage of using this method is the relative ease for regulatory agencies to 
apply and its results are expected to be conservative as long as the mixture of concern is 
less potent than the surrogate mixture.  However, the criteria for determining “sufficient 
similarity” are vague and the selection of the surrogate mixture is difficult.  Further, this 
method does not take into consideration substituted versions of PAHs in the mixture that 
can represent a significant percent of the total mass.   
 Comparative potency is also a mixture-based approach that evaluates the potency 
of the whole mixture rather than just the PAH component(s) of the mixture.  A key 
underlying assumption is that similar mixtures in a data set act in a similar manner 
toxicologically and the relative potency in an in vivo or in vitro bioassay is directly 
proportional to the relative potency in humans (Versar et al., 2002).  This proportionality 
is represented by a scaling factor, k, that is assumed to be the same for different PAH 
containing mixtures.  Further, the mixtures used to derive the scaling factor and the 
mixtures of concern must be “sufficiently” similar.   
 The main advantage of this particular mixture-based approach is that it estimates 
the potency of the whole mixture and it uses existing epidemiological data on human 
carcinogenicity of mixtures (Schoeny, R., Muller, P., and Mumford, J., 1998).  However, 
mixtures from the same types of sources (i.e. diesel emissions) do not always have 
similar ratios of PAHs or equivalent toxicological potency in which case they are not 
considered “sufficiently” similar.  Currently, this method is only useful for inhalation 
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routes of exposure because epidemiological data for human oral and dermal exposures 
are not yet available.  Consequently, it is only feasible to use in cases where inhalation 
risk will be the dominant contributor to the overall risk estimates.  This method is not 
considered a viable option for mixtures that have originated from unknown sources or 
that are poorly characterized. 
A component- based approach that is commonly used to evaluate the risk of a 
complex mixture of PAHs is the relative potency factor approach.  This method for 
mixtures risk assessment relies on existing EPA risk assessment information on single 
chemical toxicity.  Generally, it is used to evaluate mixtures of polychlorinated 
biphenyls (PCBs), dioxins and PAHs (USEPA, 2000).  Relative potency factors (RPFs) 
or toxic equivalency factors (TEFs) are used to adjust a compounds toxicity based on a 
reference compound in the same class.  The term “relative potency factor” refers to 
toxicity comparisons from an individual experiment, while the term “toxic equivalency 
factor” is most commonly used for toxicity estimates determined by consensus (USEPA, 
2000)  Compounds are included for those which TEF values can be determined.  
Complete representation of all compounds in the mixture is not guaranteed.   
This method assumes that the toxicity of individual PAHs is additive and that all 
PAHs have the same mode of action.  Additionally, it assumes that the potency of the 
carcinogenic PAHs sufficiently reflects the potency of the entire mixture.  Commonly in 
practice, the mixture of concern is from an unknown source or the composition of the 
mixture is not fully characterized.  This method can be applied to such situations with 
relative simplicity because there are existing TEFs for PAHs.  A component-based 
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approach is generally considered less desirable than a whole mixture approach.  The 
most accurate representation of risk using this method can only be calculated for the oral 
exposure route because there are currently no cancer slope factors for dermal and 
inhalation routes.  Furthermore, it is not clear whether the toxicity of individual PAHs is 
additive.  The RPF method is the least desirable method for assessing the risk for a 
complex mixture of PAHs.  In most cases, however, this is the method that must be used 
due to the nature and available data for the PAH mixture of concern (Versar et al., 2002).   
The focus of the proposed research is on PAHs and chemical mixtures of PAHs.  
This group of chemicals represents a class of environmental organic pollutants to which 
we are regularly exposed (Afghan, B. and Chu, A., 1989).  Characterized by two or more 
fused  aromatic rings, PAHs are usually crystalline solid materials that have high melting 
points, low vapor pressures, low water solubility, and strong adsorption affinity for 
surfaces (Table 1) (Afghan, B. and Chu, A., 1989; Dabestani, R. and Ivanov, I., 1999).  
These physico-chemical  characteristics make this group of chemicals especially 
important when considering routes of exposure in a risk assessment.  Their 
characteristics are typical of contaminants that can be in high concentrations in 
environmental media (i.e., soils).   
Pyrolysis of any material containing carbon and hydrogen can lead to the 
formation of PAHs.  The product composition depends primarily on the temperature for 
a given source material.  At combustion temperature below 700°C the majority of the 
PAHs formed are alkyl substituted PAHs while temperature greater than 1000°C leads to 
the formation of unsubstituted compounds (Guerin, M. R., 1978).  Accordingly, PAHs 
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that stem from coal-derived products and crude oils have an abundance of alkyl 
substituted PAHs.   
Classification of PAHs is determined by the arrangement of the rings during 
formation.  There are numerous possibilities for PAH compounds therefore the 
International Union for Pure and Applied Chemistry (IUPAC) has delineated a set of 
rules for naming PAH compounds.  There are only a select number of compounds that 
are given trivial names such as fluorene, chrysene, and pyrene (Figure 1).  The 
numbering system is determined by orienting the compound so that the maximum 
numbers of rings are in a horizontal row and as many rings as possible are above and to 
the right of that row (Harvey, R. G., 1997).  Numbering starts with a carbon atom that is 
only part of one ring, is in the most counterclockwise position on the ring farthest to the 
right above the horizontal plane, and continues in a clockwise direction.  As not all 
compounds are given a trivial name, they are assigned a name by adding the name of the 
substituent to the base trivial name.  The base name takes into account the maximum 
number of rings (Harvey, R. G., 1997).   
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Table 1. Table of physical-chemical properties of selected PAHs. 
(ATSDR, 1990a, 2005; IARC, 1983) 
 
Molecular 
Weight  
Solubility Vapor 
Pressure 
Log Kow Carcinogenicity 
  at 25 °C at 25 °C (Log Koc)   
PAH 
(g) (µg/L) (mm Hg)     
Naphthalene 128.2 12500 to 
34000 
1.8x 10-2 3.37 NC 
Acenaphthylene 152.2 3420 10 -3 - 10-4 4.07 
(3.40) 
NC 
Acenaphthene 154.2     3.98 
(3.66) 
NC 
Fluorene 166.2 800   4.18 
(3.86) 
NC 
Anthracene 178.2 59 2.4x 10-4 4.5 (4.15) NC 
Phenanthrene 178.2 435 6.8x 10-4 4.46 
(4.15) 
NC 
2-Methylanthracene 192.3 21.3   4.77 NC 
9-Methylphenanthrene 192.3 261   4.77 NC 
1-Methylphenanthrene 192.3 269   4.77 NC 
Fluoranthene 202.3 260   4.90 
(4.58) 
NC 
9,10-
Dimethylanthracene 
206.3 56   5.13 NC 
Benzo[a]fluorene 216.3 45   5.34 NC 
Benzo[b]fluorene 216.3 29.6   5.34 NC 
Pyrene 202.1 133 6.9x 10-7 4.88 
(4.58) 
NC 
Benz[a]anthracene 228.3 11 1.1x 10-7 5.63 
(5.30) 
C 
Chrysene 228.3 1.9   5.63 
(5.30) 
WC 
Benzo[b]fluoranthene 252.3 2.4   6.04 
(5.74) 
C 
Benzo[j]fluoranthene 252.3 2.4   6.21 C 
Dibenzo[a,h]fluorene 266.3 0.8   6.57 WC 
3-Methylcholanthrene 267.3 0.7   6.64 SC 
Benzo[ghi]fluoranthene 214.2 0.5   6.78 NC 
Benzo[a]pyrene 252.3 3.8 5.5x 10-9 6.06 
(5.74) 
SC 
* NC= non-carcinogenic; WC=weakly carcinogenic; C=carcinogenic; SC=strongly carcinogenic; 
Kow=Octanol /water partition coefficient; Koc= partitioning coefficient for organic carbon 
   8
 
Naphthalene             Fluorene 
 
Anthracene         Phenanthrene 
 
Fluoranthene     Pyrene 
 
Chrysene 
 
 
Figure 1. Polycyclic aromatic hydrocarbons that are used as the basis for the 
International Union of Pure and Applied Chemists (IUPAC) nomenclature 
determinations. 
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The lower molecular weight PAHs (e.g., 2 to 3 ring group of PAHs such as 
naphthalenes, fluorenes, phenanthrenes, and anthracenes) are acutely toxic to aquatic 
organisms, whereas the high molecular weight PAHs, 4 to 7 ring (from chrysenes to 
coronenes) are not due to their solubility.  However, several members of the high 
molecular weight PAHs have been shown to be carcinogenic (Table 1).  The greatest 
concern about PAHs is their carcinogenic potential.  Carcinogenicity appears to increase 
with the molecular size until 4- and 5-ring molecules are reached (Afghan, B. and Chu, 
A., 1989).  The general relationship of structure to carcinogenic potential favors the 4-, 
5-, and 6-membered ring PAHs rather than smaller, 3-ring structures, or larger 7-ring 
structures (Afghan, B. and Chu, A., 1989).  For example, one of the most toxic PAHs, 
Benzo(a) pyrene, is a 5-ring PAH and has an oral cancer slope factor of 7.30, an 
indicator of a strong carcinogen (USEPA, 2006d).   
Although PAHs have been linked to a wide range of toxic effects (i.e., cancer, 
renal disease, circulatory disorders), the parent compounds are not believed to be the 
cause of these effects (ATSDR, 1990a).  It is the oxidized metabolites and their reactive 
intermediates that are more biologically active (Pitot, H. C. and Dragan, Y. P., 1996; 
Sims, P. et al., 1974).  Metabolism of the PAH family begins with oxidation by the 
cytochrome P450-family, specifically, CYP1A1 (Figure 2).  This induction process is 
initiated by the absorption of a PAH by a cell from systematic circulation.  Once the 
PAH is in the cytosol, it binds with the Aryl Hydrocarbon (Ah) receptor.  Upon binding 
with its ligand, the Ah receptor releases two heat shock proteins (hsp 90) which are 
normally associated with the receptor in its inactive state.  This disassociation of the heat 
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shock proteins allow the Ah receptor-ligand complex to be phosphorylated by tyrosine 
kinase.  Next, the Ah receptor and its  
 
 
 
 
Figure 2. BAP as a model of PAH metabolism (IARC, 1983) 
 
 
ligand enter the nucleus and form a heterodimer with the Ah receptor –nuclear 
translocator protein (Arnt).  The heterodimer then binds with a Xenobiotic Response 
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Element (XRE) or the Dioxin Response Element (DRE) in the upstream regulatory 
region of a gene to enhance transcription (Parkinson, A., 1996).   
PAHs are ubiquitous in the environment and are routinely found in food, water, 
air, and sediment.  PAHs have been identified at 600 of the 1,420 USEPA NPL 
sites(ATSDR, 1996).   A product of incomplete combustion, PAHs are prevalent and 
inconsistent, with respect to composition, in the environment.  Wild fires, volcanoes, 
transportation and smoking are among the many sources of PAHs (Baum, E. J., 1978).  
The U.S. EPA estimated that 40% of all BAP comes from home wood fires (ATSDR, 
1990b).  Accordingly, 98% of BAP emissions are to the air and only 1% is to the soil 
and water.  However, this number can be deceiving because it represents emissions only.  
BAP and other PAHs that are emitted into the air are eventually deposited on the soil 
and on surface waters.  Most PAHs do not dissolve easily in water, therefore binding to 
particles and depositing in soils are significant transport phases.  Some PAHs will 
eventually migrate through the soil and contaminant groundwater.   
Due to the extensive and persistent contamination of media by PAHs, the 
USEPA has many mechanisms in place to regulate and monitor these compounds.  
Congress enacted the Comprehensive Environmental Response, Compensation, and 
Liability Act (CERCLA), commonly known as Superfund, on December 11, 1980 to 
authorize two kinds of response actions: short-term removals and long-term remedial 
responses.  Long-term remedial responses can only be conducted on sites that are listed 
on the USEPA’s National Priority List (NPL).  The NPL is a list of sites among the 
known releases or threatened releases of hazardous substances, pollutants, or 
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contaminants throughout the United States and its territories.  Sites on the NPL have a 
hazard ranking score (HRS) greater than 28 (USEPA, 2006c).  Several factors are 
considered in the HRS including the potential for migration off site, magnitude of 
contamination, proximity to sensitive receptors, and the toxicity of compounds present.   
USEPA and the Agency for Toxic Substance and Disease Registry (ATSDR) 
must also maintain a list of chemicals and mixtures commonly occurring at NPL sites.  If 
a chemical or mixture is listed, then priority is given to gather and characterize the 
toxicological properties of these substances.  There are currently 275 compounds and 
mixtures on the ATSDR list of which 26 are PAHs or their source materials (ATSDR, 
2005).   
The release of PAH containing materials is regulated under the Resource 
Conservation and Recovery Act (RCRA) (USEPA, 2005).  RCRA also designates a code 
for hazardous wastes based on the hazard they represent.  This designation consists of a 
letter (F, K, D, U, or P) and three numbers.  For example, single PAHs are given a U 
code, meaning they are regulated for toxicity.  Most notably, this act provided the 
framework for the disposal of both hazardous and non-hazardous wastes.  The 
Hazardous and Solid Waste Amendments (HSWA) of 1984 further strengthened the 
EPA’s ability to regulate waste disposal.  The HSWA was responsible for the eventual 
removal of land disposal of hazardous wastes.   
Cancers, renal disease, circulatory disorders, reproductive disorders, and immune 
system dysfunction are among the more common endpoints observed from PAH 
exposure in mammals (ATSDR, 1990a; Ramos, K. S. et al., 1996).  The fields of 
   13
toxicology have focused on the high molecular weight PAHs because of their well-
characterized genetic toxicity (ATSDR, 1990a, 1996).   
Chronic PAH exposure resulted in liver tumor formation yet, cytotoxicity was 
not observed at low doses in experimental animals (Moslen, M. T., 1996).  The most 
commonly encountered non-cancer effects are enzyme induction and interference with 
cell-to-cell communication.  The induction of CYP1A1 is often used as a measure of the 
biological activity of Ah receptor ligands.  This is an essential set in the induction of 
Cytochrome p450 enzymes.  Till and colleagues (1999) studied PAH induction of 
CYP1A1 in male Wistar rat hepatocyctes.  Induction of this enzyme by PAHs was 
measured as a function of CYP1A1 catalyzed 7-ethoxyresorufin-O-deethylase (EROD) 
activity.  Some of the most active inducers of this enzyme were chrysene, BAP, indeno 
(1, 2, 3-cd) pyrene, and benzanthracene.  This same study also tested smaller PAH 
compounds such as anthracene and fluoranthene.  Interestingly, they found that the 
induction potential of the mixture of the tested PAHs was greater (i.e. synergistic) than 
what was expected based on the individual PAHs (Till, M. et al., 1999).  These results 
imply that the additive assumption used is mixture risk assessment is an inaccurate 
representation of the true toxicity. 
Gap junction intercellular communication (GJIC) is an important cellular 
mechanism for maintaining homeostasis in multicellular organisms.  Downregulation of 
GJIC is considered an important epigenetic effect (Barhoumi, R. et al., 1993).  Several 
PAHs are known to inhibit GJIC.  For example, 1- and 9-methylanthracene each 
significantly inhibited GJIC at 50% of the control value (IC50) at 22 and 36µM (Upham, 
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B. L. et al., 1998).  In this same study, anthracene and 2-methylanthracene did not inhibit 
GJIC at concentrations up to 350µM (Upham, B. L., Weis, L. M., and Trosko, J. E., 
1998).  In similar experiments, BAP significantly suppressed GJIC in Clone 9 
hepatocytes following dosing with 0.4µM BAP for 16hrs (Barhoumi, R. et al., 2000).  It 
has been suggested that PAHs that contain a bay region, or which have a methyl group 
that forms a “bay-like” region, are more potent inhibitors of GJIC than their linear 
counterparts (Upham, B. L., Weis, L. M., and Trosko, J. E., 1998). 
The most sensitive endpoint for PAH toxicity effects is carcinogenicity 
(Bostrom, C. E. et al., 2002; Schoeny, R., Muller, P., and Mumford, J., 1998; USEPA, 
1993) A challenge regularly faced with evaluation of PAH carcinogenicity is their 
occurrence in the environment as mixtures and rarely as individual compounds.  Some of 
the earliest evidence of carcinogenicity of PAH mixtures occurred over 200 years ago in 
London, England.  A London surgeon, Sir Percivall Pott, described a high frequency of 
what at the time was know as “soot-wart” in chimney sweeps.  “Soot-wart” was later 
discovered to be cancer of the scrotum due to their regular exposure to soot in the 
chimneys (Pitot, H. C. and Dragan, Y. P., 1996).  The USEPA’s Integrated Risk 
Information System (IRIS) database categorizes seven PAHs as probable human 
carcinogens (Table 2).   
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Table 2. Class B2 PAH carcinogens as classified by the USEPA. 
 
 
Chemical Name CASN 
Number of 
Rings 
Chrysene 218-01-9 4 
Benzanthracene 56-55-3 4 
Benzo(b)fluoranthene 205-99-2 5 
Benzo(k)fluoranthene 207-08-9 5 
Benzo(a)pyrene 50-32-8 5 
Dibenzo(a,h)anthracene 53-70-3 5 
Indeno(1,2,3-cd)pyrene 193-39-5 6 
 
 
One study examined the carcinogenicity of BAP and two different manufactured 
gas plant residues (MGPRs) (Rodriguez, L. V. et al., 1997).  MGPR, a complex mixture 
of PAHs, is generated as a by-product of coal gasification.  Fifteen-day-old male mice 
(B6C3F1) were dosed with a single IP injection of BAP or one of two MGPRs.  The 
mice were then sacrificed at 26, 39, and 52 weeks and examined for tumor presence.  
The most predominant tumors were seen in the liver.  At 39 weeks after exposure, mice 
dosed with the MGPR samples exhibited a liver tumor incidence of between 45% and 
82% depending on the amount of BAP present in the samples.   Mice that were treated 
with 250µg BAP showed a tumor incidence of 38% with 1.9 tumors/mouse, while mice 
that were treated with 375µg BAP exhibited 65% tumor incidence and 1.9 
tumors/mouse.  These results suggest that BAP is not responsible for the observed 
tumorgenicity of the MGPRs.  Instead, the MGPR tumorgenicity could be due to other 
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unidentified components of the mixture or synergistic interactions between mixture 
components (Rodriguez, L. V. et al., 1997).  In this case, the observed tumorgenicity of 
the MGPR was greater than what would have been expected based on the known 
carcinogenic PAH components of the mixture and on the additive assumption for PAHs. 
Additional research is needed to fully understand the carcinogenicity of 
individual PAHs, PAH mixtures, and substituted PAHs.  Improving the methods for risk 
assessment of PAHs and PAH mixtures is dependent upon increased knowledge of the 
toxicity and carcinogenicity of these compounds.  Methods to estimate toxicity of PAHs 
and PAH mixtures based on structure and known activity, is an inventive way to begin to 
further explain the observed toxicity.   
Quantitative structure-activity relationships (QSARs) are multi-variant statistical 
correlations between an expressed chemical property and the key geometric or chemical 
characteristics of a molecular system.  QSARs are constructed by analyzing known 
and/or calculated property information and a set of descriptors that represents the system 
attributes (Gombar, V. A., 1998). A QSTR, which is a QSAR developed for a toxicity 
metric, is a mathematical relationship between a given toxicity metric and numerical 
descriptors of molecular structure (Gombar, V. A., 1998).  These models allow for the 
prediction of toxicity solely from a chemical structure.  For example, Koenemann (1981) 
developed the following relation: 
Log (1/LC50) = 0.871logP – 4.87                                        Eqn. 1.1 
This equation relates the partition coefficient, P, of a chemical and its acute toxicity 
(LC50) in a guppy.  If the only available data for a chemical was the partition 
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coefficient, the value of the median lethal concentration for a guppy could be calculated 
using this equation (Koenemann, H., 1981).  QSAR models can predict toxicity using 
empirical relationships if (1) the predictive QSTR model is statistically robust and (2) 
the QSTR model is not only applicable to the query chemical but also chemicals 
“similar” to the query chemical (Gombar, V. A., 1998).   
 Building reliable QSTRs from bioassay data requires constraints in development.  
The bioassay data must be as uniform as possible because a QSTR can only predict what 
the bioassay results represent.  If a researcher develops a model for mutagenicity using a 
variety of mutagenicity assays, a variety of species, and different exposure durations and 
routes, the developed QSTR would not be valid for prediction.   The chemical might be 
mutagenic to some species but not all; likewise, the exposure time for a mutagenic 
response may be different for some species.  It is important that the criteria of uniformity 
in the bioassay protocols be strictly adhered to so that the developed database from 
which to derive the QSTR is valid and consistent for that scenario and for similar 
chemicals in the same bioassay (Debnath, A., 2001).    
 After selecting bioassay parameters and constraints and choosing information-
rich descriptors, the QSTR can now be developed.  Building a robust, relevant model 
begins with identifying a training set of chemicals to be analyzed.  The individual 
models are representative of the activity of similar compounds, for example, the family 
of PAH compounds or PCBs.  Thus a model developed for amino acids would not be 
valid for estimating toxicity of PAHs.  Next, for each of the molecules to be analyzed, 
their observed biological data is entered and the appropriate descriptors calculated.  
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There are thousands of descriptors that can be used to describe the biological activity of 
a compound; spatial, electronic, topological, information-content, thermodynamic, 
conformational, quantum mechanical, and shape descriptors are just a few 
(AccelrysSoftwareInc., 2005).  The descriptors are analyzed for correlation and 
uniformity from which appropriate dependent and independent variables are identified.  
Several statistical methods are available for generating a QSTR equation. These include 
multiple linear regressions, partial least squares (PLS), simple linear regression, stepwise 
multiple linear regression, principal components regression (PCR), or genetic function 
approximations (GFA).  Next, validation and analysis of the QSTR equation by applying 
techniques to identify outliers and leverage points are performed. Characterizing the 
robustness of the QSTR is accomplished using graphical analysis and cross-validation.  
The calculated QSTR equation can now be used to predict biological activity of 
compounds similar in structure to the training set of compounds. 
The hypotheses that have driven this research are: 
 (1) The toxicity of PAHs and substituted PAHs may be estimated using bioassay 
based QSAR models, and; 
(2) The additive assumption does not adequately estimate the true toxicity of PAHs 
in complex mixtures.   
  To test these hypotheses there were three objectives investigated.  The first 
research objective was to test seven PAH compounds and four PAH mixtures in a set of 
three bioassays.  Each bioassay measures a different toxic endpoint that is significant in 
human health risk assessment.  Secondly, the data that was generated from each bioassay 
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was used to generate QSAR models for each bioassay.  Each QSAR model can be used 
to estimate the specific toxic endpoints of each bioassay for PAHs, substituted versions 
of PAHs and mixtures of PAHs.  Finally, the additive assumption for mixtures that is 
commonly used in risk assessment practices was examined using these models.  The 
results from the specific models was used to determined if the additive effects from 
individual compounds was the same as the mixture results from the bioassays.  The 
combination of the responses from the three bioassays was used to generate an empirical 
weighted equation.  This equation can be used to estimate toxicity factors, such as 
relative potency factors or toxic equivalency factors. 
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CHAPTER II 
MODELING TOXIC ENDPOINT FOR IMPROVING HUMAN HEALTH RISK 
ASSESSMENT OF POLYCYCLIC AROMATIC HYDROCARBONS (PAHs) – 
PARENT COMPOUNDS AND SIMPLE MIXTURES 
Overview 
 Risk assessments for mixtures of polycyclic aromatic hydrocarbons (PAHs) are 
problematic due to the lack of available potency and toxicity data on individual 
compounds and mixtures.  This paper examines the toxicity of parent compounds and 
designed mixtures of PAHs in order to bridge the gap between component assessment 
and mixture assessment of this class of ubiquitous compounds.  The objective for this 
research was to test seven parent PAH compounds and four PAH mixtures in a set of 
three bioassays to evaluate the toxicity of parent compound PAHs and binary mixtures 
of PAHs.  PAHs and mixtures were examined in the Salmonella/Microsome 
Mutagenicity Assay, a Gap Junction Intercellular Communication (GJIC) assay and the 
7-ethoxyresorufin-O-deethylase (EROD) assay.  These assays were chosen for their 
ability to measure specific toxic endpoints related to the carcinogenic process (i.e. 
initiation, promotion, progression).  Two compounds similar in structure, BAP and 
benzanthracene, consistently produced positive results in all three bioassays.  While a 
linear PAH, anthracene, produced negative results in all three bioassays.  An 
antagonistic response was observed for the mixtures in all three bioassays.  Chemical 
structure was important in explaining the observed responses.  Chemical structure 
relationships with activity and the steps of the carcinogenic process can be used to 
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improve estimates of toxicity for compounds and mixtures for human health risk 
assessments. 
Introduction 
 Chemical exposures for people commonly occur in the presence of multiple 
chemicals.  The effect on toxicity for one chemical in the presence of another is not well 
understood.  Currently, more than 7 million chemicals exist and approximately 70,000 
are in common use while 1000 are added each year worldwide 
(Government.Accountability.Office.(GAO), 1994).  Research efforts have focused 
primarily on the toxicology of individual chemicals.  As a result, risk assessment 
practices using available toxicity data have evaluated individual chemical exposures, 
ignoring the complexities of multiple chemical exposures.  Although the dilemma of 
predicting the human health risks of exposure to chemical mixtures is not new, the 
challenges presented by chemical mixtures risk assessment remain unmet.  This is due in 
part to the lack of a clear framework and methodology for mixtures assessment and 
because there are many individual components of mixtures that are not toxicologically 
characterized.  Rarely do single PAHs occur in the environment; rather exposures are to 
multiple compounds in mixtures.  There are more than 100 PAHs that can be quantified 
by GC/MS analysis but many more substituted PAHs, degradation products, and parent 
compounds that cannot yet be identified.  Of those that can be identified 16 are routinely 
quantified by the USEPA (USEPA, 1993).  How chemicals interact when an individual 
is exposed to a mixture is largely unknown.   
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To estimate the toxicity of mixtures, the USEPA developed standardized 
approaches to estimate risk (USEPA, 1993).  The three approaches commonly used are: 
(i) toxicity data for the specific mixture of concern; (ii) extrapolating data from a similar 
mixture; and, (iii) toxicity of the individual components of a mixture (Versar, I. and 
Associates, B. S., 2002).  Although mixture approaches for assessing risk are preferred, 
mixture specific toxicity data are not always available.  In such cases, component-based 
approaches are the most common technique for assessing risk.  In the case of PAHs, 
individual PAH toxicity data is lacking and component –based methods are necessary to 
perform risk assessment estimates.   
 One such component method used for PAHs is the relative potency factor 
approach, also known as the toxic equivalency factor (TEF) approach.  TEFs were first 
developed for polychlorinated biphenyls (PCBs) as a way to rank their potency relative 
to 2,3,7,8-tetrachlorodibenzodioxin (TCDD) (Safe, S. H., 1990).  Similar approaches 
have been used to develop TEFs for PAHs.  In the case of PAHs, TEFs are developed for 
cancer effects and therefore encompass a broad range of toxic endpoints.  Some of the 
first researchers to develop TEFs for PAHs were Chen and Chu (1984) and Clement 
Associates(1988) (Nisbet, I. and LaGoy, P., 1992).  These two works are limited in that 
they only address a small number of the PAHs that are commonly found at hazardous 
waste sites.  Further, they are unreasonably precise.  These two works were used as a 
basis for the commonly used set of TEFs developed by Nisbet and LaGoy (1992) which 
were order of magnitude estimates.   
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 In 1993, the Office of Environmental Health Assessment (OHEA) issued a 
provisional guidance document for implementing TEFs for PAHs (USEPA, 1993).  The 
state of knowledge for the implementation of TEFs for PAHs revealed the lack of 
information about PAH toxicity, interactions, and their promotional effects.  
Consequently, the TEF method for assessing risk is limited.  Under EPA’s guidance, the 
only logical alternative for PAHs is to use order of magnitude estimates called potential 
potencies (USEPA, 1993).  Prior to potential potencies, EPA separated PAHs into 
carcinogens and non-carcinogens and used the cancer slope factor assigned to BAP for 
all carcinogenic PAHs (Nisbet, I. C. and LaGoy, P. K., 1992; USEPA, 1993).     
Complex mixtures consist of tens, hundreds, or even thousands of constituents.  
Most often, their composition is not fully known and can change with time.  Adequate 
testing of such mixtures is virtually impossible because the mixture is unavailable for 
testing, the composition of the mixture is changing, and a sufficient number of doses 
cannot be applied.  Effort to determine if the toxicity of a mixture is different from the 
sum of the toxicities of the single constituents has been reported in several studies 
(ATSDR, 1990a; Barata, C. et al., 2005; Bostrom, C. E. et al., 2002; Reeves, W. R. et 
al., 2001).  The toxicity of a mixture depends on the exposure level, the mechanism of 
action, and the receptor for each of the mixture constituents (Feron, V. J., Woutersen, R. 
A. et al., 1995; Groten, J. P. et al., 2001; Henschler, D., 1996).  Another hurdle of 
mixture testing is the different types of effects that can occur at high-dose levels and 
low-dose levels, making low-dose extrapolation dubious (Feron, V. J., Groten, J. P. et 
al., 1995; Henschler, D., 1996).   The two hypotheses that drive this study are: (1) The 
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toxicity of PAHs, mixtures of PAHs, and substituted PAHs may be estimated using 
bioassay based TEFs that take into account the process of carcinogenesis; and, (2) the 
additive assumption does not adequately estimate the true toxicity of PAHs in complex 
mixtures.  To test these hypotheses seven parent PAH compounds and four PAH 
mixtures were evaluated in a set of three bioassays for their toxicity.    
In evaluating PAHs with regard to human health, carcinogenicity drives the risk 
assessment.  In recent years the TEF methodology has been used to assess the risk 
associated with exposure to a mixture of PAHs (Nisbet, I. C. and LaGoy, P. K., 1992; 
USEPA, 1993).  To develop bioassay based TEFs for PAHs the multistage process of 
cancer that involves genotoxic and epigenetic events should be considered.  In this study, 
bioassays were chosen for their ability to measure both initiation and promotion related 
effects of carcinogens.  Each bioassay measures a different toxic endpoint that is 
significant to the process of carcinogenicity (Pitot, H. C. and Dragan, Y. P., 1996; 
Reeves, W. R. et al., 2001).  The limitation of TEFs to accurately predict the toxicity of 
mixtures has been addressed by targeting initiation and promotion related effects to 
understand the relationship between mixture composition and toxicity.  
Bioassays were chosen for their ability to measure both initiation and promotion 
related effects of carcinogens.  Following initiation, a series of events leads to the 
initiated cells’ promotion and the eventual progression to a rapidly growing malignant 
cell.  A genotoxic event can be responsible for the initiation of cancer, however 
promotion and progression may include a variety of epigenetic events (Trosko, J. E. et 
al., 1998).  Each compound was tested in the Salmonella/microsome assay, the Gap 
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Junction Intercellular Communication assay (GJIC) and in the ethoxyresorufin-O-
deethylase assay (EROD). 
The Salmonella/microsome assay measures mutations of DNA which are linked 
to initiating events (Ames, B. N. et al., 1975a; McCann, J. and Ames, B. N., 1976; 
McCann, J. et al., 1975; Zeiger, E., 1998). Cytochrome P450 mono-oxygenases are 
active in the metabolism of many xenobiotics.  Alkoxyresorufin-o-deethylase substrates 
have been used to distinguish isoforms of P450 induced by various types of xenobiotics.  
Induction of the cytochrome P450 family of enzymes has been shown to be an essential 
step in the activation of carcinogens prior to initiation (Kennedy, S. W. and Jones, S. P., 
1994; Szklarz, G. D. and Paulsen, M. D., 2002). The impairment or elimination of a 
cell’s capability to communicate with other cells is believed to promote tumor growth by 
eliminating signals that instruct an initiated cell to stop dividing (Couch, D. B., 1996; 
Trosko, J. E. et al., 1998; Trosko, J. E. and Ruch, R. J., 1998).  Measuring GJIC between 
cells serves as an indicator of a PAH’s ability to impair this function.  Using bioassay 
based data from specifically targeted endpoints to estimate a TEF or potential potency 
will allow for a toxicity estimate specific to a chemical’s toxic potential in each step of 
carcinogenesis.  TEFs or potential potencies are only estimates of toxicity, however, 
failing to take into account both initiation and promotion effects limit their ability to 
predict toxicity.  Separation of initiation and promotion effects revealing the relationship 
between composition and toxicity of these compounds and mixtures of these compounds 
is a goal of this study.   
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The multistage carcinogenic process includes multiple mechanisms such as gene 
and/or chromosomal mutations (genotoxic events), altered gene expression at several 
(transcriptional, translational, post-translational) levels (epigenetic events), and changed 
cell survival (necrosis/apoptosis).  A toxicant could potentially bring about one or all of 
these mechanisms.  Using three different bioassays, each measuring a specific stage of 
carcinogenesis, may reveal the dominant mechanisms and lead to more appropriate 
toxicity estimation.   
Materials and Methods 
Cell Culture 
 The liver cell line, Clone 9 (ATCC, CRL 1439, passage 17) was used for the 
GJIC and EROD experiments.  The Clone 9 cell line exhibits gap junctions as detected 
by electron microscopy and is inducible for EROD (Barhoumi et al., 2000).  Cultures 
were used within 10 passages after being received and maintained in Ham’s Nutrient 
Mixture F-12 containing 10% fetal bovine serum.  For EROD measurements, cells were 
seeded at 90,000 cells/well in 2-well Lab-Tek chamber slides and incubated until they 
were approximately 80% confluent.  For the GJIC assay, cells were seeded in 2-well 
Lab-Tek Chamber slides at 50,000 cells/cm2 and incubated for 24 hours before use.   
Binary Mixture Preparation 
 Binary mixtures of BAP with 5-methylchrysene and BAP with chrysene were 
prepared in DMSO.  The ratio of constituents in the mixture was 1 to 1.  Each mixture 
was tested in two separate arrangements such that each chemical was held at a constant 
concentration and mixed with varying concentrations of the second chemical.  For 
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example, BAP was held at 10mM while varying concentrations (10mM to 0.5mM) of 
chrysene were added at a 1:1 ratio.  The second arrangement of these two chemical held 
chrysene constant at 10mM while varying BAP concentrations (10mM to 0.5mM) were 
added at a 1:1 ratio.  For the GJIC and EROD assays, these mixtures were diluted 
(DMSO final concentration less than 0.5%) in medium. 
EROD 
 EROD assays were performed in quadruplicate with Clone 9 cells using a 
modified version of the 48-well microplate fluorometric assay derived from Donato et 
al., 1993 and Kennedy et al., 1995.  Cells were seeded in 2-well Lab-Tek slides and 
allowed to incubate 24 hours before treatment was applied.  PAHs were dissolved in 
DMSO (final concentration less than 0.5%) to give final concentrations of 1µM and 
10µM.  After an exposure period of 24 hours, 50µl of EROD (10µM) was added to the 
treatment well to start the reaction.  The addition of 100µl of fluorescamine (150 µg/ml) 
stopped the reaction after a 10-minute period.  Following a 5-minute period for 
fluorescence stabilization, the resorufin concentrations were measured using a Zeiss 
Stallion system (Carl Zeiss, Thornwood, NY).  Excitation and emission wavelengths 
were set to 530/590 nm for measuring EROD.  Fluorescence intensity is proportional to 
resorufin formed  and responses were in the linear response range.  Results from each 
treatment were compared using a one-way ANOVA and Tukey’s test.  Significance was 
set at p< 0.05 (Appendix A). 
GJIC 
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GJIC was measured in the Clone 9 cells by dye coupling.  The rate constant of 
dye transfer between cells obtained using a fluorescence recovery after photobleaching 
(FRAP) technique used by Barhoumi et al, 1993.  Stock solutions of 2mg/ml 5-
carboxyfluorescein diacetate (CFDA) in DMSO were diluted to 10µg/ml in medium.  
PAH solutions (final concentrations ranging from 0.5µM to 10µM) were prepared in 
DMSO and diluted in medium such that the concentration of DMSO never exceeded 
0.1%.  Cells were seeded in 2-well Lab-Tek Chamber slides at 50,000 cells/cm2 and 
incubated for 24 hours.  Cells were dosed with 1µl/ml of chemical treatment at five 
doses.  Following 24 hours of incubation at 37.5oC the medium was removed; cultures 
were washed 3 times with PBS.  CFDA solution (10µg/ml) in serum free medium 
without phenol red was added (10µl) and the cells were again incubated at 37.5oC for 15 
min.  Loading times below saturation were used to avoid the presence of unconjugated 
dye that could lead to overestimation of GJIC.  After dye was loaded, cultures were 
washed three times in PBS and maintained in serum-free medium without phenol red.  A 
microscopic field of groups of cells was selected for analysis.  Within these groups of 
cells, single cells served as photobleached negative controls.  Similarly, single cells or 
small isolated groups of nonphotobleached cells were used as positive controls.  Positive 
controls were used to monitor background photobleaching from image scans and 
increases in fluorescence due to unconjugated dye.  Selected cells were photobleached to 
a level that allowed for observance of fluorescence recovery without damaging the cells.  
After Cells were scanned for fluorescence recovery and with a Meridian Ultima confocal 
workstation (Meridian Instruments, Okemos, MI).  Data was collected for at least 30 
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cells in two culture wells per treatment.  A rate constant (k) for the fluorescence 
recovery was estimated by fitting the percent fluorescence intensity at a given time, F(t), 
to the following equation: 
F(t) = Feq (1-e-kt) + F(0)                                         Eqn. 2.1 
Feq represents the percent fluorescence recovery of the bleached cell at 
equilibrium and F(0) represents the percent fluorescence intensity immediately following 
photobleaching.  The value of Feq is dependant on the number of cells contacting each 
other and their initial level of bleaching.  Therefore, data from at least 30 cells from each 
treatment were pooled to obtain the mean Feq and k values.  Extrapolation of 
fluorescence recovery over time was accomplished using curve fitting regression 
analysis (GraphPad Software).  Results from each treatment were compared using a one-
way ANOVA and Tukey’s test.  Significance was set at p< 0.05 (Appendix A).   
Salmonella/microsome Assay 
The Salmonella/microsome assay was used to test the mutagenicity of PAH 
compounds.  The Salmonella typhimurium strain TA98 was provided by Dr. B. N. Ames 
(University of California, Berkeley).  The samples were dissolved in DMSO (final 
concentrations ranging from 0.5mM to 30mM) and tested with and without metabolic 
activation using the S9 fraction of Aroclor 1254-induced Sprague-Dawley rat liver 
(Molecular Toxicology, Inc., Boone, NC).  Each pre-poured plate containing 25 ml of 
VBX bottom agar, 2.5ml of top agar (0.5mM histidine, 0.5mM biotin) received 1-2 x 109 
cells, 0.5 ml of 20% S9 (sodium phosphate buffer was used for plates without metabolic 
activation), and 50µl of chemical, mixture, or control.  Each sample was tested on 
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duplicate plates in two independent experiments.  The plates were then incubated for 72 
hours at 37°C.  The number of revertant colonies for each treatment was determined 
using an Artek Model 880 automatic colony counter (Dynatek Laboratories, Chantilly, 
VA).  A response was considered positive if the average number of revertants at two or 
more consecutive concentrations exceeded twice the average number of revertants in the 
corresponding negative solvent control, and at least two of these consecutive 
concentrations showed an increasing number of revertants with increasing dose (Chu, K. 
C. et al., 1981).  Media preparation and other methods followed those of Maron and 
Ames (1983).  All bioassays included positive, negative, and solvent controls.  Results 
from each treatment were compared using a one-way ANOVA and Tukey’s test.  
Significance was set at p< 0.05 (Appendix A). 
Materials 
 Ham’s Nutrient Mixture F-12, Dulbecco’s phosphate-buffered saline, serum, 
Dimethyl Sulfoxide (DMSO), methanol, acetonitrile, all general chemical reagents, and 
PAH compounds were purchased from Sigma Chemical Co. (St. Louis, MO).  
Fluorescamine, Resorufin, and 7-Ethoxyresorufin used in the EROD assay were also 
purchased from Sigma Chemical Co (St. Louis, MO).  Tissue culture flasks and dishes 
were obtained from BD Falcon (Bedford, MA).  Coverglass chambers were purchased 
from Nunc (Naperville, IL).  5-carboxyfluorescein diacetate (CFDA) was purchased 
from Molecular Probes (Eugene, OR).   
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Results  
Parent Compounds 
Salmonella/Microsome Assay 
A positive response in the Salmonella/microsome assay resulted if the average 
number of revertants at two or more consecutive concentrations exceeded twice the 
average number of revertants in the corresponding negative solvent control, and at least 
two of these consecutive concentrations showed an increasing number of revertants with 
increasing dose (Chu, K. C. et al., 1981).  Using this rule, naphthalene and anthracene 
failed to produce positive results at any of the doses tested with metabolic activation 
(Table 3).  The DMSO control produced 36 ± 7 revertants/plate while, naphthalene, and 
anthracene produced a maximum of 39 ± 2, and 47± 7 revertants, respectively.  
Chrysene produced a weakly positive result over three doses tested (Table 3).  5-
methylchrysene produced a positive result at the four doses tested greater than 0.5mM.  
BAP produced positive results at all five doses tested with the minimum response at 
30mM producing 243 ± 10 revertants/plate.  Benzanthracene also produced positive 
results at 30, 10, and 3mM.  The maximum response was observed at 10mM, which 
produced 199 ± 2 revertants/plate.    Chrysene and 5-methylchrysene were the only two 
chemicals tested at 20mM because these two compounds would not stay in solution at 
30mM.  All other compounds (Anthracene, Naphthalene, BAP, and Benzanthracene) 
tested were at a maximum concentration of 30mM.   
 
 
 
 
   32
 
 
 
 
 
 
 
 
Ta
bl
e 
3.
 T
ot
al
 re
ve
rta
nt
s i
n 
th
e 
Sa
lm
on
el
la
/m
ic
ro
so
m
e 
as
sa
y 
pr
od
uc
ed
 b
y 
ea
ch
 c
he
m
ic
al
 a
nd
 D
M
SO
 c
on
tro
l w
ith
 m
et
ab
ol
ic
 
ac
tiv
at
io
n.
 
   33
GJIC 
 Intercellular communication in Clone 9 hepatic cells are reported as a rate of 
recovery (min-1) from the photobleaching process.  A significant reduction in the rate of 
recovery is relative to a standard and is compared to each treatment.  BAP showed 
strong inhibition at doses of 10, 5, and 2µM, where the rate of recovery (min-1) was 
0.3679 ± 0.002, 0.456 ± 0.003, and 0.532 ± 0.005, respectively (Figure 3).  Similarly, 5-
methylchrysene showed strong inhibition at all of the doses tested.  Benzanthracene also 
showed significant inhibition at doses of 10µM and 5µM where the rate of recovery 
(min-1) was 0.4441 ± 0.004 and 0.563 ± 0.007, respectively.  Chrysene did produce 
slight inhibition at the two low doses tested (1 and 0.5 µM) and at the highest dose tested 
(10µM).  Phenanthrene and anthracene did not produce any response that was 
significantly different from DMSO with the exception of phenanthrene at 0.5µM where 
the rate of recovery (min-1) was 0.543 ± 0.002.  However, the 0.5 µM phenanthrene dose 
is the lowest of these tested.   
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Figure 3. Inhibition of gap junction intercellular communication by parent compound 
PAHs in Clone 9 cells.  Values shown are mean k values for at least 30 cells tested from 
two culture dishes per treatment. 
 
 
EROD 
 The EROD assay measures the rate of the CYP1A-mediated deethylation of the 
substrate 7-ethoxyresorufin to form the product resorufin as indicated by an increase in 
fluorescence intensity relative to the control.  All of the chemicals tested induced 
responses that were significant when compared to control at both doses tested (Figure 4).  
Anthracene and 5-methylchrysene induced significantly lower responses (353.9±3.15 
and 369.2±7.2, respectively) than did the other chemicals tested at 10µM (Figure 4).  
Chrysene, benzanthracene, BAP, and phenanthrene all induced similar responses at 
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10µM (Figure 4).  Phenanthrene and BAP induced slightly lower responses (417.9±6.35 
and 436.5±8.93, respectively) than did chrysene and benzanthracene (468.2±4.72 and 
467.4±12.48, respectively).  At the lower dose tested (1µM), benzanthracene induced the 
greatest response (517.5±10.08) followed by phenanthrene and chrysene (477.3±2.98 
and 399.8±8.47, respectively) (Figure 4).  Anthracene, BAP, and 5-methylchrysene 
induced the three lowest responses (378.4±11.40, 350.5±6.24, and 333.1±5.99, 
respectively) among the chemicals tested at 1µM.  Chrysene, BAP, 5-methylchrysene, 
and benzanthracene were consistently among the highest inducers at both concentrations 
tested while anthracene was the lowest inducer tested at both concentrations.  BAP 
induced a higher response at the higher concentration tested than at the lower 
concentration.  One of the useful aspects of CYP1A induction for biomonitoring 
purposes is the enzyme’s tendency to increase in concentration upon chemical exposure.  
This is observed here with increased expression at the higher concentration of BAP, 
chrysene, and 5-methylchrysene.       
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Figure 4.  EROD activity for parent compound PAHs in Clone 9 cells.  Fluorescence 
intensity was measured in two culture dishes per treatment with cells at 90% confluency.  
Values represent the mean response for each treatment. 
 
 
PAH Mixtures 
Salmonella/Microsome Assay 
 Four mixture combinations of BAP, chrysene and 5-methylchrysene were tested 
in this bioassay (Table 4, Figure 5).  Using the 2-fold rule (Chu, K. C. et al., 1981),  both 
arrangements of the BAP and 5-methylchrysene mixtures produced positive results at the 
three doses tested when compared to the control (Table 4, Figure 5).  BAP alone at 
30mM produced 292±17 revertants, yet when 5-methylchrysene was added at varying 
concentrations the response was less than that for BAP alone resulted.  The addition of 
5-methylchrysene reduced the effective toxicity of BAP in this assay.  Less than additive 
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response in the mixture resulted as compared to the individually tested compounds 
which was statistically significant in Tukey’s Test at the p<0.05 level.   
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Figure 5. Salmonella/microsome assay results for parent compound PAHs and PAH 
mixtures. 
 
 
Similarly, when a constant concentration of 5-methylchrysene was amended with 
varying BAP concentrations, additivity was not observed (Table 4, Figure 5).  As a 
single compound, 5-methylchrysene was mutagenic (101±9 revertants) at 20mM.  
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Increasing the concentration of BAP in the presence of 20mM 5-methylchrysene did 
increase the mutagenicity but not in an additive manner.  There was approximately a 
50% decrease in the expected additive response (393 revertants) and the observed 
response (197 revertants).    
Two mixture arrangements for BAP and Chrysene were also compared and both 
resulted in positive responses over three consecutive doses (305±13, 299±17, and 
278±11, respectively) but the responses were not additive.  When varying amounts of 
Chrysene were added to BAP (30mM), there was a positive response (Table 4, Figure 5) 
that was not statistically significant from that of BAP alone.  The mixture response was 
significantly lower than that of the expected additive response (Table 4, Figure 5) 
showing that the additive assumption over-estimated the response in this case.   
Varying amounts of BAP added to Chrysene (20mM) show a 50-70% decrease in 
the expected additive response.  While chrysene (20mM) alone resulted in 87±2 
revertants, the addition of BAP resulted in an approximate doubling of revertants at the 
three highest doses test (30mM, 10mM and 3mM, respectively).  The results of the 
mixture response were less than additive.  There was an antagonistic effect observed in 
the mixture when compared to the response of BAP alone, indicating an interaction 
between Chrysene and BAP in this mixture that was statistically different at p<0.05.  
The additive assumption in this case over-estimated the response by more than double 
the number of revertants in some cases.  At lower doses of BAP (1mM and 0.5mM), the 
response was similar to that of Chrysene alone.  This could indicate that the toxicity 
expected due to BAP was inhibited by an interaction with Chrysene at these lower doses.   
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Chrysene and 5-methylchrysene were the only two chemicals tested at 20mM because 
these two compounds would not stay in solution at 30mM.  BAP was tested at a highest 
concentration of 30mM.  
GJIC 
 The response of each mixture arrangement was compared to the control response 
of 0.822±0.008 min-1.  BAP (10µM) mixed with varying concentrations of chrysene 
showed the most significant inhibition of cellular communication (Figure 6).  Increasing 
concentrations of Chrysene were added to BAP (10µM), resulted in a  statistically 
significant decrease in cellular communication.  Generally, the higher the chrysene 
concentration the slower the rate of recovery was.  Only at 0.5µM chrysene was the 
response similar to the control (Figure 6).  The largest decrease in communication was 
observed for BAP (10µM) mixed with chrysene at 5µM.  The rate of recovery for this 
combination was 0.037±0.005 min-1 compared to 0.822±0.008 min-1 for the control.  
When BAP was analyzed alone at 10µM (Figure 6) the rate of recovery was 
0.469±0.011 min-1, therefore the reduced communication cannot be attributed to BAP 
alone. 
 In comparison, chrysene at 10µM with varying concentrations of BAP responses 
did not show significant decreases in communication between 10, 5, and 2µM of BAP 
added (Figure 6).  The lowest rate of recovery was 0.607±0.011 min-1 and was observed 
when BAP at 10µM and 5µM was added to chrysene (10µM).  This rate was 
significantly different from the control rate (0.822±0.0083 min-1) at the p<0.05 level.  
Similarly, the rate was significantly different from chrysene tested alone at 10µM that 
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produced a 0.568±0.006 min-1 rate of recovery.  These responses indicate that some 
inhibition between the chemicals in this mixture could have prevented them from fully 
affecting the cellular communication.  When this combination is compared to the 
previous arrangement, chrysene appears to be the inhibiting compound and not BAP.  
When chrysene was added in varying concentrations, communication was significantly 
inhibited except at a concentration of 5µM chrysene.  However, when chrysene was held 
at a constant concentration and varying concentrations of BAP where added, the same 
inhibition was not observed.  
 Two arrangements of BAP and 5-methylchrysene mixtures were also tested.  
When 5-methylchrysene was added in varying concentrations to BAP (10µM), there 
were significant differences in the rates of recovery at two of the concentrations tested 
(Figure 6).  The lowest rates of recoveries (0.527±0.002 min-1 and 0.542±0.005 min-1, 
respectively) for this arrangement were observed for the addition of 0.5µM and 10µM 5-
methylchrysene were added to 10µM BAP.  These rates of recovery were lower than that 
observed for BAP (10µM) (0.603±0.011 min-1, respectively) tested alone.  These results 
suggest that when 5-methylchrysene was mixed with BAP (10µM), a chemical 
interaction alone was not likely to be causing the observed result, but a physiochemical 
(i.e. transport, solubility) phenomena could explain the observed results.   
  When varying concentrations of BAP were added to 10µM of 5-methylchrysene, 
the rates of recovery were significantly repressed (Figure 6).  The lowest rate of 
communication occurred when BAP at 10µM was mixed with 5-methylchrysene (10µM) 
(0.421±0.003 min-1).   
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EROD 
EROD activity describes the rate of the CYP1A mediated deethylation of the 
substrate 7-ethoxyresorufin to form the product resorufin which can be measured 
fluorometrically.  The induction of these enzymes is a vital step in the activation of 
carcinogens prior to initiation and increase in the fluorescence intensity is directly 
related to increased toxicity.  As in previous experiments with these mixtures, there were 
two arrangements of each mixture tested.  Typically, the additive assumption for mixture 
responses was not observed in any of the mixtures tested using the EROD assay. 
For the mixture of BAP and chrysene at 10µM each, the response (420.3±9.16) 
was similar to the response observed for each of the chemicals alone (Figure 7).  Neither 
there was an additive effect nor did the chemical mixture show any increase in induction 
when compared to the experiments with the single chemicals.  Similarly, this was 
observed in the mixture containing BAP and 5-methylchrysene at 10µM.  There was not 
an additive effect observed with these two chemicals.  The result (477.0±7.08) was not 
significantly different from the result produced by BAP alone.  
 In the case of BAP held at a constant concentration, (10µM) and 5-
methylchrysene added at 1µM, the result was similar to that observed for 5-
methychrysene tested alone at 1µM (Figure 7).  There was not an additive effect 
observed with this mixture; the result being similar to that of 5-methylchrysene alone 
might indicate an inhibition of the activity of BAP in the presence of 5-methylchrysene.  
The mixture arrangement composed of 5-methylchrysene held at a constant 
   43
concentration (10µM) and BAP added at 1µM showed the opposite result.  The result for 
the mixture was similar to the result for BAP tested alone at 1µM.   
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 Figure 6. In Inhibition of gap junction intercellular communication by PAH 
mixtures in Clone 9 cells.  Values shown are mean k values for at least 30 cells tested 
from two culture dishes per treatment. 
 
 
The mixture of chrysene held at a constant concentration (10µM) and BAP added at 
1µM produced similar results as observed in the previous mixture of chrysene and BAP 
at 10µM each.  The result (419.8±14.2) was similar to that observed for chrysene alone 
at 10µM.  BAP did not produce an observable effect on chrysene in this mixture.  The 
mixture arrangement of BAP held at a constant concentration (10µM) combined with 
chrysene at 1µM showed significant inhibition when compared to the chemicals tested 
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alone.  Enzyme induction in this case (309.2±4.8) was significantly lower than either 
chemical tested alone and lower than the assumed additive effect (Figure 7). 
Discussion 
 To predict toxicity of carcinogens for assessing human health risk it is important 
to take into account each stage of carcinogenesis and the effect that two or more 
chemicals in mixture have on the process.  The Salmonella/microsome assay is a simple, 
quick, and inexpensive genotoxicity assay which is one of several required for product 
safety testing of a variety of materials including drugs, medical devices, food additives, 
industrial chemicals, and pesticides.  The Salmonella/microsome assay measures 
mutations of DNA, important initiating events of the carcinogenic process (Ames, B. N., 
McCann, J., and Yamasaki, E., 1975a; McCann, J. and Ames, B. N., 1976; McCann, J. et 
al., 1975; Zeiger, E., 1998).  There is considerable evidence, using this test and with few 
exceptions, that carcinogens are mutagens (Ames, B. N., McCann, J., and Yamasaki, E., 
1975a; Ames, B. N. et al., 1975b; McCann, J. and Ames, B. N., 1976; Miller, E. and 
Miller, J., 1971).  However, some disadvantages of this test were encountered.   
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The chemical concentrations needed to elicit a response in this strain of bacteria are not 
environmentally relevant.  In using such high concentrations, solubility limits are 
exceeded for some of the PAHs tested however the presence of DMSO kept the PAH in 
solution.  For example, chrysene, is known to be a weak carcinogen,  was dosed at its 
solubility limit of 20mM in DMSO and elicited a weak positive response.  Another 
concern with this assay is that the toxicity of some chemicals can mask genotoxic 
potential.  If a compound is toxic to the bacteria, then the bacteria is killed resulting in a 
false negative result.  The results observed in this assay followed the hypothesized 
response of the chemicals containing a bay region being mutagenic and those linear 
counterparts being non-mutagenic (Ames, B. N., McCann, J., and Yamasaki, E., 1975a; 
McCann, J. and Ames, B. N., 1976; McCann, J. et al., 1975).  Although chrysene has 
two bay regions, it is considered a weak carcinogen (McCann, J. et al., 1975; Donnelly, 
K. C. et al., 2004).  Due to the high concentration of chrysene used in this experiment, it 
is possible that the toxicity masked some of the genotoxic potential in this set of 
experiments.   
Evaluation of the mixture responses in the Salmonella/microsome assay yielded 
slightly antagonistic responses.  The mixture of chrysene held constant and BAP added 
in varying concentrations produced the most antagonistic effects among the mixtures of 
BAP and chrysene.  The expected additive response was as much as 30% higher than the 
observed response.  However, at the two highest doses of BAP and chrysene together, in 
two different assays, the response was 61% lower than the expected additive response.  
A similar response was seen when 5-methylchrysene was held constant and BAP was 
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added in varying concentrations.  Antagonistic effects were greater in the mixture of 5-
methylchrysene held constant and BAP added.  However, the response at the highest 
doses of the two chemicals did not show significant difference between the two 
experiments (approximately 13% difference).   
A greater antagonistic response in this assay would indicate that the interaction 
of these two chemicals in mixture reduces their initiation potency.  It has been 
documented that chrysene and BAP both bind with DNA at the N2 position.  
Competition for binding sites is an explanation for the observed results and was also 
observed by Warshawsky and Landolph (2006).  While the observed effects could 
indicate mixture interaction effects, the mechanism of this antagonistic behavior is most 
likely competition for binding sites on the DNA.  The Salmonella/microsome assay has 
been historically used to screen carcinogens as mutagens.  However, using the results 
from this assay alone to predict behavior of PAHs in mixture would not be accurate due 
to the limits of sensitivity in this assay.   
The GJIC experiments for the parent compounds with bay-regions were shown to 
cause inhibition.  Many investigators have shown that PAHs containing a bay or “bay-
like” region inhibit gap junction communication to a greater extent than do their linear 
counterparts (Rummel, A. et al., 1999; Weis, L. M. et al., 1998; Blaha, L. et al., 2002; 
Upham, B. et al., 1996).  Bay-like regions, as referred to in this study, represent the 
angular pocket formed at the top of the benzene ring by a methyl group.  The regions are 
structurally similar to the sterically hindered bay regions that are formed by angular 
benzene rings.  In this study, BAP and 5-methylchrysene were both strong inhibitors of 
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GJIC and both possess bay or “bay-like” regions.  Similar responses, at a lower level of 
inhibition, were seen for benzanthracene and chrysene.  In contrast, chrysene, with two 
bay regions, produced rates of recoveries higher than expected.  This could be due in 
part to the steric hindrances of the two bay regions of this molecule (Singer, B. and 
Grunberger, D., 1983). The two bay regions being in such close proximity to each other 
cause the molecular shape to change due to the strain of the atoms close together which 
results in the inhibition observed.  
 The mixture with BAP held constant and at varying concentrations of chrysene 
resulted in the most inhibited cellular communication.  When chrysene at 10, 5, and 
2µM was added to BAP (10µM) the communication results indicated a synergistic effect 
where the presence of both chemicals reduced the toxicity of each.  Conversely, the 
opposite combination of the same chemicals did not produce similar results.  Other 
investigators have shown that structural dependences such as higher molecular mass and 
higher lipophility (Kow) affect GJIC inhibition (Blaha, L. et al., 2002).  Both BAP and 
chrysene are similar in structure and are known to promote tumors.  An apparent effect 
is related to which compound is held at a constant concentration.  Inhibition potency 
could be contributed to one or many physiochemical characteristics of the individual 
PAHs in the mixture.  Another contributing factor could be the influence of total mixture 
concentration.  The higher the total concentration of the mixture the greater effect on 
communication was observed (Figure 6).   
 The mixtures of BAP and 5-methylchrysene were inhibitory to GJIC between 
cells when 5-methylchrysene was constant at 10µM and BAP was added.  There were 
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not significant differences between concentrations of BAP added, nor was there a dose 
related response.  An additive response was not observed in either arrangement of the 
mixture.  Alone, 5-methylchrysene inhibited communication (0.3212±0.002 min-1) to a 
greater extent than when mixed with varying concentrations of BAP.  An additive 
assumption to estimate the toxicity of this mixture would have resulted in a large 
inhibition of communication considering both compounds have bay regions.  The 
observed results suggest that BAP and 5-methylchrysene have an effect on one another 
that disables or reduces an additive effect on cellular communication.  Weiss et al, 
(1998) found that PAHs with bay regions inhibited cellular communication to a greater 
extent than did their linear counterparts (Weis, L. M. et al., 1998).   In the case of 5-
methylchrysene, a methylation of the parent compound, chrysene, creates the “bay-like 
region.”  It has been reported in other studies (Upham, B. et al., 1996; Weis, L. M. et al., 
1998; Upham, B. L. et al., 1994) that methylated PAHs inhibit gap junction 
communication more than the unmethylated versions.  Considering these previous 
studies and the results of this study, 5-methylchrysene induces only a slightly additive 
inhibitory effect on communication when mixed with BAP. 
Both 5-methylchrysene and BAP have been shown to be potent inhibitors of 
GJIC (Blaha, L. et al., 2002; Krutovskikh, V. et al., 1994; Trosko, J. E. et al., 1998).  
The inhibition observed in this study cannot be attributed solely to BAP or 5-
methylchrysene activity individually.  Rather, the observed response is most likely 
contributed to interactions between the two chemicals or a combination of interactions 
and physiochemical properties of the two chemicals.  If 5-methychrysene, with its “bay-
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like” region, acted differently than other PAHs containing a bay or “bay-like” regions 
then a purely additive response would not be expected.   
 The bay region of 5-methylchrysene is crowded by the methyl substitution and 
therefore can act as a non-planar compound.  The electrostatic and steric interactions 
between the protons across the crowded bay region can destabilize the planar structure 
resulting in a helical shaped molecule (Rabinowitz, J. et al., 2002).  These interactions 
between the proton across the bay region and the epoxide oxygen may decrease the 
reactivity of the diol-epoxide (Rabinowitz, J., Little, S., and Brown, K., 2002).  The 
energy needed to make 5-methylchrysene become planar is relatively small compared to 
other compounds but small perturbations such as the less ordered aqueous environments 
can cause 5-methylchrysene to act as if it were non-planar (Rabinowitz, J., Little, S., and 
Brown, K., 2002).  For these reasons, 5-methylchrysene cannot be expected to always 
act as a planar PAH in in vitro biological studies and less toxicity will be observed as 
was the case in this study.     
Several investigators have proposed the mechanism by which GJIC is disrupted.  
Due to the rapid occurrence of GJIC inhibition many believe that the mechanism of 
action is at the posttranslational level, specifically a modification of the gap junction 
proteins (Yamasaki, H., 1995; Rummel, A. et al., 1999; Upham, B. et al., 1996; Blaha, 
L. et al., 2002).  In this study, rapid occurrence of GJIC suppression was also observed 
suggesting that this mechanism is primarily at the posttranslational level as well.     
 EROD activity for these compounds and mixtures was not conclusive.  The 
induction of EROD was concentration dependent for BAP, chrysene, and 5-
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methylchrysene.  However, the same result was not seen for anthracene, phenanthrene, 
and benzanthracene.  Anthracene and phenanthrene induced similar amounts of EROD 
at both concentrations tested.  Both of these compounds are similar in structure and 
induced relatively similar amounts of EROD.  Anthracene has been shown to be a weak 
inducer of EROD in other studies (Falahatpisheh, M. et al., 2004).  It is known that 
induction of CYP1A is mediated through the binding of xenobiotics to a cytosolic aryl 
hydrocarbon receptor (AhR) (Safe, S., 2001).  Anthracene is not a strong AhR ligand 
and did not produce responses at either concentration that were significant when 
compared to control.  Although, phenanthrene is also not considered a strong AhR 
ligand, at the lower concentration of 1µM, one of the highest responses among the 
chemicals tested was observed. 
 There is an apparent similarity in protein inducability among structurally related 
PAHs.  The behavior of PAHs in the EROD assay seems to be influenced by the 
reactivity of the oxidative intermediates that are generated during the course of 
metabolism (Basu, N. et al., 2001; Safe, S., 2001; Falahatpisheh, M. et al., 2004).  
Therefore, each compound’s metabolic pathway plays an important role in the induction 
of EROD. 
 The mixture combinations of BAP and 5-methylchrysene, while showing there 
was not an additive effect on induction, did reveal increased induction over either of the 
chemicals tested alone.  This could be due in part to a saturation effect of the chemicals 
in the mixture.  There were similar responses with both arrangements of this mixture; 
increasing the concentration of either chemical did not affect the overall response.  
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Chrysene and BAP in a mixture at the same concentration showed the same effect as 
chrysene mixed with a smaller concentration of BAP.  Again, although the response was 
not additive, the slight inhibitory effects on the induction of enzymes cannot be 
attributed solely to one specific chemical.  Induction of the detoxifying enzyme, EROD, 
encoded by both CYP1A1 and CYP1B1, was inducible by all the chemicals and 
mixtures tested and should be proportional to the exposure concentration.  Other 
investigators have shown chrysene to inhibit the inducibility by BAP in mixtures and to 
yield irregular responses in this assay (Falahatpisheh, M. et al., 2004).  This could be due 
in part to chrysene or 5-methychrysene inhibiting the transformation of BAP to 
metabolites that are more toxic or the competition of the chemicals for metabolizing 
enzymes (Petrulis, J. R. et al., 2001; Brunstrom, B. et al., 1991; Falahatpisheh, M. et al., 
2004).  These interactions would cause antagonistic interactions that shield against 
additional chemical toxicity.   
 The helical structure of 5-methylchrysene supports a theory of antagonistic 
interaction.  The steric effect at the site of methyl substitution may alter the 
radioselectivity of oxidation by the metabolizing enzymes.  The radioselectivity would 
direct the metabolism at other regions of the molecule resulting in the production of 
metabolites that would inhibit the transformation of BAP to its ultimate carcinogen and 
thus producing more carcinogenic 5-methylchrysene metabolites (Rabinowitz, J., Little, 
S., and Brown, K., 2002; Schoeny, R., Muller, P., and Mumford, J., 1998; Shappell, N. 
W. et al., 2003).  Shappell, et al (2003) in a study of the metabolites of both chrysene 
and 5-methylchrysene in trout and rat liver microsomes confirmed this result.  They 
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concluded that metabolizing enzymes of trout and liver microsomes were more efficient 
in attacking the bay region double bond in chrysene and the non-bay region double bond 
of 5-methylchrysene resulting in different metabolites.  The radioselective differences of 
these two compounds may result in the ease of enzymatic activation to the ultimate 
carcinogenic bay region diol-epoxides thus inhibiting the transformation of BAP by the 
detoxifying enzyme, EROD, to its ultimate carcinogenic metabolite.   
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CHAPTER III 
USING QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS (QSARs) TO 
PREDICT TOXIC ENDPOINTS FOR POLYCYCLIC AROMATIC 
HYDROCARBONS (PAHs) 
 
Overview 
 
 Quantitative Structure-Activity Relationships (QSARs) offer a reliable, cost-
effective alternative to the time, money, and animal lives necessary to determine 
chemical toxicity by traditional methods.  Additionally, humans are exposed to tens of 
thousands of chemicals in their lifetime necessitating a need to predict chemical toxicity 
and screen for those posing the greatest risk to human health.  This study developed 
models to predict toxic endpoints for three bioassays specific to the stages of 
carcinogenesis.  The ethoxyresorufin- O-deethylase assay (EROD), Salmonella/ 
microsome assay and a gap junction intercellular communication (GJIC) assay were 
chosen for there ability to measure toxic endpoints specific to activation, induction, and 
promotion related effects of PAHs.  Shape-Electronic, Spatial, Information Content, and 
Topological descriptors proved to be important descriptors in predicting the toxicity of 
PAHs in these bioassays.  Predicting toxicity for a specific PAH compound, such as a 
bioassay-based potential potency (PPB) or a bioassay-based toxic equivalency factor 
(TEFB), is possible by combining the predicted behavior from the Quantitative Structure 
Toxicity Relationship (QSTR) models.  These toxicity estimates can then be 
incorporated into a risk assessment for compounds that lack toxicity data.  It is believed 
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that accurate toxicity predictions can be made by examining each type of endpoint 
important to the process of carcinogenicity and a clearer understanding between 
composition and toxicity can be obtained.   
Introduction 
   It is estimated that there is little to no toxicity data available for  more than 75% 
of  chemicals in use today (Gombar, V. A., 1998).  Experimental testing of new and 
existing chemicals require approximatly 730 days and $2,000,000 US to conduct 
carcinogenicity testing for one chemical (Gombar, V. A., 1998).  It is imperative in these 
times of shrinking resources for experimental research, that an efficient, timely, and less 
costly method be used to test chemicals for environmental and human health risks.  
 Using quantitative structure-activity relationships (QSARs) to estimate toxicity 
of chemicals is a practical an efficient approach, however limitations of use must be 
recognized.  QSARs developed for a specific toxicity metric are also referred to as 
quantitative structure-toxicity relationships (QSTRs), and serve to predict toxicity of a 
chemical based on that chemical’s structure.  QSARs can also reveal mechanisms of 
interaction.  One such example from Koenemann (1981) of a QSTR is the relationship 
between the partitioning coefficient, P, of a chemical and its acute toxicity to a guppy 
(Equation 3.1).  If only given a chemicals’ partitioning coefficient, P, can be 
approximated the value of the mean lethal concentration (LC50) to a guppy.   
 
log (1/LC50) = 0.871(log P) – 4.87                  Eqn.3.1 
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There have been QSTRs developed for some toxic endpoints of PAHs (Braga, R. S. et 
al., 2000; El-Alawi, Y. S. et al., 2002; Govers, H. et al., 1984; Lewis, D. F. V. and Parke, 
D. V., 1995) and models of physiochemical properties for PAHs (Abraham, M. H. et al., 
2005a).  The predictive equations are applicable for a family of compounds and may not 
be appropriate for a different family.   
 The driving hypothesis of this study was that PAH toxicity can be predicted 
using QSTRs and can further improve toxicity assessments in human health risk 
assessment.  The objective of this study was to develop QSTRs describing the toxic 
endpoint of PAHs in three individual bioassays.  Each bioassay was chosen based on the 
importance of the measured endpoint in the process of carcinogenicity.  Carcinogenicity 
is one of the driving force behind human health risk assessment of chemicals such as 
PAHs.  Due to the lack of toxicity information for several parent compound PAHs, 
methylated versions of the parent compounds, and mixtures of PAHs, QSTRs provide a 
means to estimate toxicity of these compounds and further reduce the uncertainty 
otherwise introduced into the risk assessment process.  These methods should be used 
with caution within a specific family of compounds.  Each QSTR is specific to the 
characteristics of the family of compounds to which it was trained.  If PAHs are 
chlorinated and the models were not trained with chlorinated PAHs, then the models 
may not reliably predict the behavior of chlorinated hydrocarbons.   
 The three bioassays chosen to generate data to train a QSTR model were the 
Salmonella/microsome assay, a gap junction intercellular communication (GJIC) assay, 
and the ethoxyresorufin-O-deethylase assay (EROD).  Results from the three bioassays 
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were interpreted with the QSTR models for applications in human health risk 
assessments.  The Salmonella/microsome assay measures mutations of DNA which are 
known to be important initiating events (Ames, B. N., McCann, J., and Yamasaki, E., 
1975a; McCann, J. and Ames, B. N., 1976; McCann, J. et al., 1975; Zeiger, E., 1998). 
Cytochrome P450 mono-oxygenases play a major role in the metabolism of many 
xenobiotics.  Alkoxyresorufin-o-deethylase substrates have been used to distinguish 
isoforms of P450 induced by various types of xenobiotics.  Induction of these enzymes 
of the cytochrome P450 family has been shown to be an essential step in the activation 
of carcinogens prior to initiation (Kennedy, S. W. and Jones, S. P., 1994; Szklarz, G. D. 
and Paulsen, M. D., 2002). The impairment or elimination of a cell’s capability to 
communicate with other cells is believed to promote tumor growth by eliminating 
signals that instruct an initiated cell to stop dividing (Couch, D. B., 1996; Trosko, J. E. et 
al., 1998; Trosko, J. E. and Ruch, R. J., 1998).  Measuring gap junction communication 
between cells serves as an indicator of a PAH’s ability to impair this function.  Using the 
data generated by these three bioassays, three major steps in the process of 
carcinogenicity are predicted and the combination of these responses for a given 
chemical can be used to estimate a bioassay based toxic equivalency factor (TEFB) or 
potential potency factor (PPB).   
 To assess the appropriateness of QSTRs for expressing toxicity as a linear 
relationship consider the initiation of cancer (Gombar, V. A., 1998).  For example, a 
necessary condition for the initiation of cancer is the formation of covalent conjugates 
with the macromolecule at the site of action.  This process leading to carcinogenesis can 
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be represented by equation 3.2 where, C is the concentration of a chemical reacting with 
Z, the concentration of the macromolecule that generates C:Z, the concentration of the 
covalent conjugate.   
    C + Z          (C:Z) = P              Eqn. 3.2 
The rate of the process of initiation could be rewritten as, 
     d(p) / dt = k3(C:Z)    Eqn. 3.3 
where k3 is the first order rate coefficient.  The resulting steady state equation will be, 
    d(p) / dt =k3 (C) * (Z) exp(-∆G/RT)              Eqn. 3.4 
where ∆G is the free energy associated with the formation of the C:Z conjugate.  
Integration of this equation over a given time period will result in,   
     P = k3 (C) * (Z) exp ( ∆G/RT) * t     Eqn. 3.5  
 
It is not feasible to measure C and Z at the reaction site, however if a set of  n chemicals 
are assumed to react with the same receptor, the R term could be considered constant.  
For a fixed value of P/t (i.e. a predefined response such as tumor formation over 5 years 
of exposure), equation 3.5 can be transformed into equation 6. 
 
  K = (Ci) exp (-∆Gi / RT)   for i = 1, 2,…, n                     Eqn. 3.6 
 
Using a simple log transformation and considering that the concentration C is 
proportional to some exposure concentration, C’, equation 3.6 can be written as, 
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  log (1/ (C’i)) = log A’i – ∆Gi / RT + K’’  for i = 1,2,…,n      Eqn. 3.7 
 
where the left-hand side of the equation is the toxicity metric, A’ is a factor which relates 
C and C’, ∆G is the free energy change associated with the formation of the conjugate 
and K’’ is the transformations on the constants.  The terms A’ and ∆G are both functions 
of a chemical’s molecular structure.  The linear free energy relationship (Equation 3.7) 
enables the expression of toxicity as a function of descriptors of the molecular structure 
(Purcell, W. P. et al., 1973).  By examining essential steps in the carcinogenic process 
(i.e. activation, initiation, and promotion), the relationship between chemical 
composition and toxicity can be obtained for a set of chemicals and applied to predict the 
toxicity of related chemicals.   
Methods and Materials 
 The datasets presented in Chapter II for PAHs in the  Salmonella/microsome 
assay, the gap junction intercellular communication (GJIC) assay, and the 
ethoxyresorufin-O-deethylase (EROD) assay were used as input data to develop QSARs.  
Biological data is normally skewed, as was the case with these datasets, and requires 
some form of transformation to normalize the data.  In this case, a logarithmic 
transformation was used to normalize the data.   
 Cerius2 4.10 molecular simulation package (Accelrys Inc., San Diego, CA) was 
used for QSAR development.  Each of the PAH molecules was imported into Cerius2 as 
a structure SD file for use in the training set.  The energy of each molecule was 
minimized using a CFF91 open forcefield (Maple, J. R. et al., 1994).  The training set of 
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molecules and its corresponding bioassay data was used to create a study table.  
Descriptors were added to the study table using Descriptor+, a module of the Cerius2 
package.  Typically, the descriptors were calculated using MOPAC7 due to the accuracy 
of this method as compared to other methods in Cerius2.  The final training set contained 
descriptors from several categories (i.e. conformational, electronic. spatial, among 
others.).  To develop QSARs for each of the bioassays, the corresponding parameter (i.e. 
revertants, rate of recovery, or fluorescence intensity) was set as the dependent variable 
and the descriptors as the independent variables.   
 QSARs were created using a genetic function approximation (GFA) algorithm 
built in the QSAR+ module of Cerius2 (Rogers, D. and Hopfinger, A. J., 1994).  The 
GFA algorithm is preferred over other traditional regression methods for two reasons.  
The GFA algorithm generates better quality equations and it provides, through study of 
the evolving models, additional information not available from standard regression 
analysis.  The algorithm generated 100 parent equations that include randomly selected 
descriptors.  Regressions were performed on the generated equations and equations were 
ordered according to their lack-of-fit (LOF) score (Friedman, J. H., 1991).   LOF scores 
are a measure of the statistical fit and an indicator of overfitting.  Crossover operations 
(repeated 20,000 times) used random pairs of parent equations and randomly mixed 
descriptors to produce offspring equations.  The offspring equation substituted the 
equation with the highest LOF if its LOF score was in the top 100, otherwise it was 
discarded.  The crossover procedures and recombination of equations resulted in an 
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improved final population of equations that were ordered according to the individual 
LOF scores.   
 Statistical analysis was performed on the final 100 equations generated by the 
GFA for each bioassay.  The relevant statistical parameters calculated were the 
correlation coefficient, R, the coefficient of determination, R2,   and the adjusted value, 
R2-adj, the lack-of-fit-score, LOF, and the least squares error, LSE.  The significance of 
the regression equations was tested using the F-test.  If the F-value is greater than a 
standard tabulated value, the equation is considered significant.  The significance level 
for the F-test was set at 0.05.   
 Validation testing was used to evaluate the generated QSARs for their 
uncertainties and predictive power using a bootstrap validation test and a randomization 
test.  The bootstrap test calculates the coefficient of determination (R2bootstrap) and the 
uncertainty associated with it.  Repetitive analysis of random samples of the dataset with 
resampling was used.  Fisher’s randomization method was used to test the assumption 
that adequate random regressions exist for a parameter thus testing the validity of the 
model and the data that was used to generate it.  Each bioassay-specific value predicted 
by the QSAR was randomly reassigned 19 times (0.05 significance level) and statistical 
parameters were recalculated each time.  These parameters were then compared to the 
non-random QSARs for each bioassay.  There are four additional statistics along with 
the previously mentioned bootstrap coefficient of determination (R2bootstrap) reported 
from the validation testing.  These include the sum of squared deviations of the 
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dependent variable values from their mean (SD), the predicted sum of squares (PRESS), 
the cross-validated R2, and the outliers. 
 
Results 
 The final QSTRs for each bioassay, potential potency factors, and TEFs are 
represented by equations 8 through 12.  These equations were among the most 
significant of the GFA equation output for each case.  The equations chosen were the 
lowest three LOF scores among the equations generated for each case.  This means that 
the GFA successfully converged to valid and useful equations.  The significant statistics 
are presented in Table 5 for each of the QSTRs.  Equations were selected based on high 
coefficients of determination and significance of the F-statistic.  To insure that equations 
were not overfitted, R2 was compared to R2-adj.  When observations were not sufficiently 
independent of one another,  even in cases with large numbers of observations,  the 
models generated can have poor explanatory and predictive power 
(AccelrysSoftwareInc., 2005).  A comparison of the R2 parameter and the R2bootstrap 
parameter shows that the calculated R2 is accurate and the probability of it being low is 
small insuring the quality of fit for each equation.   
 
Log (Fluorescence Intensity) = 4.31258 + 0.484167 * Kappa-1           Eqn. 3.8 
                + 0.500625 * Jurs-WNSA-3 
 
Log (Net Revertants) = 8.4492 + 0.0009 * E-DIST-mag            Eqn. 3.9 
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     -0.0164 * Jurs-TASA 
 
 
Log (Rate of Recovery) (min-1) = -4.35035 + 0.426617 * CIC                            Eqn. 3.10 
                  + 5.44241 * Shadow-XYfrac   
                   - 0.00709 * Jurs-PNSA-1       
 
Log (Potential Potency) = -1.8891 – 0.0180 *Vm            Eqn. 3.11 
          + 0.0086 * PMI-mag 
 
Log (TEF) = -6.9378 +0.8266 * Jurs-WNSA-3           Eqn. 3.12 
            + 0.0219 * PMI-mag 
 
Comparison of measured and calculated toxic endpoints using equations 3.8-3.12 are 
shown with 95% confidence intervals for each bioassay in Figures 8-12.  The diagonal 
line on each graph represents the 1:1 relationship.  Proximity of the data to the line 
indicates that the predicted QSAR response was the same as the actual bioassay 
response. 
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Figure 8.  QSTR for EROD activity by PAHs in Clone 9 cells.  Actual bioassay response 
versus QSTR predicited response. 
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Figure 9.  QSTR for revertants in Salmonella /microsome assay.  Actual bioassay 
response versus QSTR predicted response. 
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Figure 10. QSTR for rate of recovery of Clone 9 cells in the GJIC assay.  Actual 
bioassay response versus QSTR predicted response. 
-4
-3.5
-3
-2.5
-2
-1.5
-1
-0.5
0
0.5
1
-4 -3 -2 -1 0 1
Actual Log Potential Potency 
Pr
ed
ic
te
d 
Lo
g 
Po
te
nt
ia
l P
ot
en
cy
 
Figure 11. QSAR model of potential potencies for PAHs.  Actual USEPA potential 
potencies versus QSAR predicted potential potencies.   
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Figure 12. QSAR of TEFs for PAHs. Actual versus QSAR predicted TEFs. 
 
 
 The significant descriptors used in equations 3.8-3.12 are from four categories: 
Shape-Electronic, Spatial, Information Content, and Topological.  The calculated values 
for the descriptors used in equations 8-12 are presented in Table 6.  The shape-electronic 
descriptors combine shape and electronic information to characterize molecules.  The 
descriptors are calculated by mapping atomic partial charges on solvent-accessible 
surface areas of individual atoms (AccelrysSoftwareInc., 2005; Stanton, D. T. and Jurs, 
P. C., 1990).  Jurs-TASA, Jurs-PNSA-1, and JURS-WNSA-3 are all shape-electronic 
descriptors.  Jurs-TASA is the total hydrophobic surface area that is the sum of solvent-
accessible surface areas of atoms with absolute value of partial charges less than 0.2.  
Jurs-PNSA-1 is the partial negative surface area that is calculated as the sum of the 
solvent-accessible surface areas of all negatively charged atoms.  Jurs-WNSA-3 is the 
surface-weighted charged partial surface area calculated as the solvent accessible surface 
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area multiplied by the partial charge for all negatively charged atoms multiplied by the 
total molecular solvent accessible surface area divided by 1000 (Stanton, D. T. and Jurs, 
P. C., 1990; Rohrbaugh, R. H. and Jurs, P. C., 1987).   
 There are three spatial descriptors that emerge as dominant: Shadow-XYfrac, 
Vm, and PMI-mag.  The Shadow-XYfrac, one of several shadow indices, is a set of 
geometric descriptors that characterizes the shape of the molecules.  The descriptors are 
calculated by projecting the molecular surface on three mutually perpendicular planes, 
XY, YZ, and XZ (Rohrbaugh, R. H. and Jurs, P. C., 1987).  These descriptors depend 
not only on conformation but also on the orientation of the molecule.  Specifically, 
Shadow-XYfrac is the fraction of the area of the molecular shadow in the XY plane over 
the area of the rectangle enclosing the projection of the molecule.  Vm is a 3D spatial 
descriptor that defines the molecular volume inside the contact surface (Hill, T. L., 
1960).  The molecular volume is calculated as a function of conformation and is related 
to binding and transport.  PMI-mag is the magnitude of the principle moments of inertia 
about the principle axes of the molecule (Hill, T. L., 1960).  Taken together these 
descriptors capture the influence of a molecule’s geometry on its behavior. 
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 Two information content descriptors that merged as significant are: E-DIST-mag, 
and CIC.  This set of descriptors is based on their calculations of the representation of 
molecular structures as graphs, where atoms are represented by vertices and covalent 
chemical bonds by edges (Bersohn, M., 1983; Muller, W. R., 1987).  E-DIST-mag is 
based on the edge adjacency and the edge distance matrices.  Specifically, it is the total 
edge distance of a molecule divided by the magnitude (Bonchev, D., 1983; Bonchev, D. 
et al., 1981; Katritzky, A. R. and Gordeeva, E. V., 1993).  CIC is referred to as the 
complementary information index.  This descriptor represents the deviation of the 
information content from its maximum possible value where the information content is 
an index of the partitioning of the valence and bonds of a chemical’s structure.  The 
Kappa indices are a set of topological descriptors that view molecule graphs as 
connectivity structures to which numerical invariants can be assigned.  Kappa indices 
specifically help to differentiate the molecules according to size, degree of branching, 
flexibility and overall shape.  Specifically, Kappa-1 describes the shape of the molecule 
in terms of the count of atoms (Kier, L. B., 1990; Kier, L. B. and Hall, L. H., 1991).  
Each of the descriptors appear in one QSTR except the PMI-mag and Jurs-WNSA-3, 
which appear in two (Equations 3.10, 3.11 and 3.12).   
Discussion 
 Enzymatic activation is a precursor to the initiation of chemicals to be DNA 
mutagens.  Induction of the enzymes of the cytochrome P450 family has been shown to 
be an essential step in the activation of carcinogens prior to initiation (Kennedy, S. W. 
and Jones, S. P., 1994; Szklarz, G. D. and Paulsen, M. D., 2002).  PAHs have been 
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linked to a broad range of toxic effects such as cancers, renal disease, circulatory 
disorders and immune system dysfunction (ATSDR, 1990a).  The parent compound 
PAHs are not believed to be the cause of these many effects.  Rather the oxidized 
metabolites and their reactive intermediates show a greater level of biological activity 
than do the unmetabolized parent compounds.  Metabolism of PAHs begins with 
oxidation by enzymes of the cytochrome P450 family, specifically CYP1A1.  The 
induction process begins with PAH absorption by a cell from systematic circulation.  
Once in the cytosol, PAHs bind with the aryl hydrocarbons (Ah) receptor and release 
two heat shock proteins (hsp 90).  The Ah receptor-ligand complex can then be 
phosphorylated by tyrosine kinase.  This allows the Ah receptor and ligand to enter the 
nucleus, bind with the Ah receptor-nuclear translocator protein (Arnt) and bind with the 
xenobiotics response element in the upstream region of a gene to enhance transcription 
(Parkinson, A., 1996).  The absorption and transport of a PAH by the cell, into the 
cytosol, can be a limiting factor in the metabolic activation process (Parkinson, A., 
1996).  Similarly, the structure of a molecule will dictate the path of metabolic 
transformation into more active intermediates.   
 The two descriptors that are used to represent the induction of P450 enzymes are 
both consistent with chemical transport and structure.  Jurs-WNSA-3 is a spatial 
descriptor that combines shape and electronic information about a molecule (Stanton, D. 
T. and Jurs, P. C., 1990).   Specifically, it is the surface weighted charged partial surface 
area.  This descriptor us highly correlated with the molecular area which is related to the 
binding, transport and solubility of a molecule (AccelrysSoftwareInc., 2005).  Recently, 
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the charged partial surface area (CPSA) descriptors have been found to be useful in the 
study of acute aquatic toxicity where they appear to provide an alternative to energy 
level measures for describing global and local electrophilicity in cases of non-covalent 
molecular interactions (Stanton, D. T. et al., 2002).   Local electrophilicity is also 
important in the metabolism of PAHs by the cytochrome P450 family of enzymes 
(Parkinson, A., 1996).  CYP1A1 contains a heme group capable of supplying singlet 
oxygen for insertion into the double bonds of PAHs.  This insertion produces epoxides.  
Cells attempt to excrete PAHs by increasing their polarity through electrophilic attacks 
using Phase II enzymes.  Unfortunately, this often results in a more biologically active 
compound.  The Jurs-WNSA-3 descriptor illustrates the importance of structure in the 
chosen position of attack to detoxify a compound by these metabolizing enzymes. 
 The Kappa-1 index or the Kier’s Shape Index-1 describes the induction of the 
metabolizing enzymes in the QSTR equation is.  This index differentiates the shape of a 
molecule based on the count of atoms.  This descriptor is also highly correlated with 
molecular volume, molecular weight, and molecular area (AccelrysSoftwareInc., 2005).   
The importance of a molecule’s shape and degree of branching and flexibility impacts 
detoxification/metabolism processes within cells (Vyas, K. P., Levin, W. et al., 1982; 
Vyas, K. P., Thakker, D. R. et al., 1982; Warshawsky, D. and Landolph, J. R., 2006; 
Szklarz, G. D. and Paulsen, M. D., 2002).  Recent studies demonstrate that absorption, 
distribution, metabolism, and excretion (ADME) properties are accurately predicted 
using topological descriptors such as the Kappa-1 index (Votano, J. R. et al., 2004).   
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 Of the three bioassays, the least amount of experimental data was available for 
the EROD assay.  A minimal dataset reduces the predictive power of equation 3.8 
somewhat because the more data that is used to train a model the more predictive power 
results.  Equation 3.8 did show a lower coefficient of determination and smaller F-
statistic (Table 5).  However, the lack-of-fit score was among the top three (Table 5).  
The result of this minimal dataset reduces the confidence in this equation.   
 The Salmonella/microsome assay measures mutations of DNA, which is an 
initiation, a critical step in the carcinogenic process  (McCann, J. and Ames, B. N., 1976; 
Zeiger, E., 1998).  Mutagenic activity is strongly influenced by several structural factors 
such as isomeric positioning, conformation, steric hindrances, physical dimension, and 
the ability to resonance stabilize the electrophilic metabolites (Ames, B. N., McCann, J., 
and Yamasaki, E., 1975b; Analogues, C. o. P. a. S. and Hazards, B. o. T. a. E. H., 1983; 
Ashurst, S. W. et al., 1983; Warshawsky, D. and Landolph, J. R., 2006).    These factors 
are consistent with the descriptors used in equation 9 for the number of revertants in the 
Salmonella/microsome assay (Table 6).  This result confirms that structure activity 
relationships can be good predictors of toxic endpoints relating to carcinogenesis.   
 The E-DIST-mag and Jurs-TASA descriptors in equation 3.9 correlate well with 
DNA revertants and have significant implication to the process of initiation.  E-DIST-
mag is an information content descriptor that represents a molecules’ physical dimension 
based on atoms and chemical bonds.  Jurs-TASA is a shape-electronic descriptor that 
characterizes the total hydrophobic surface area of a molecule.  Two important aspects in 
DNA mutation are intercalation and hydrophobicity (lypophilicity) (Pitot, H. C. and 
   74
Dragan, Y. P., 1996; Roy, D. R. et al., 2006; Singer, B. and Grunberger, D., 1983).  
Intercalation of PAHs with DNA is a fundamental process in which aromatic molecules 
associate directly with DNA by fitting into the minor and major groves of the helix 
(Geacintov, N. E., 1986).    The degree of intercalation is related to the lypophilicity 
(hydrophobicity) that determines the ease of transport within the cell.  Therefore, the 
negative coefficient of Jurs-TASA means that decreasing the total hydrophobic surface 
area of a molecule would increase the ease of transport within a cell.  Once a mutagen 
(e.g. a PAH) crosses the cell membrane, the controlling factor for binding with 
hydrophobic DNA is the hydrophobic nature of the mutagen and lowering of the energy 
of the system possibly through pi-driven (π-π interaction) intercalation.  The process of 
pi-driven intercalation is most efficient if aromatics are electron deficient.  This 
deficiency facilitates electrostatic attraction between electron rich centers on the 
nucleotides and the electron deficient centers on the aromatic.  PAHs are known to be 
efficient intercalators with the optimum size being three and four ringed structures.   
 The positive coefficient for E-DIST-mag means that a greater edge distance will 
increase the binding affinity resulting in a greater number of revertants.  A greater edge 
distance means there are more covalent chemical bonds and less steric hindrance.  Steric 
effects occur when atoms within a molecule, having and occupying a certain amount of 
space, are brought too close together (Harvey, R. G., 1991; Cancer), I. I. A. f. R. o., 
1983).  There is an associated cost in energy due to the electron clouds overlapping 
affecting the molecular shape and reactivity (Harvey, R. G., 1997).   
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 The spiral shape of DNA is such that one groove is bigger than the other.  This 
has some advantages for compounds or drugs that bind to it because they too are 
different sizes.  Bigger molecules bind in the major grooves of DNA, while small 
molecules bind in minor grooves.  PAHs and their metabolites intercalate between 
adjacent base pairs or can form adducts.  Therefore, less steric hindrance allows a 
molecule to readily intercalate with the DNA.  Similarly, the physical dimension of a 
molecule with less steric hindrance more readily bonds to the DNA.    
 The GJIC assay measures the impairment or elimination of a cell’s capability to 
communicate with other cells.  This communicative ability between cells controls 
several important functions such as growth control, homeostasis, and cellular apoptosis.  
The elimination of this communication between cells is believed to promote tumor 
growth by eliminating signals that instruct an initiated cell to stop dividing (Couch, D. 
B., 1996; Trosko, J. E. et al., 1998; Trosko, J. E. and Ruch, R. J., 1998).  The structure-
toxicity relationship for the rate of recovery in the GJIC assay is expressed in descriptors 
from three categories: information content, spatial and shape-electronic.  CIC is an 
information content descriptor that corresponds to the steric qualities of a molecule.  
Steric hindrance or strain will cause a molecule to change its shape and reactivity 
(Harvey, R. G., 1997).  These changes in shape and reactivity can modify the gap 
junction proteins which can extend the inhibition of GJIC (Rummel, A. et al., 1999).   
 The rate of recovery for GJIC is embodied in the Shadow-XYfrac.  This 
geometric descriptor characterizes the shape of the molecule and depends not only on the 
molecular conformation but on orientation as well.  Shadow-XYfrac is calculated by 
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projecting the molecular shape on the three Cartesian planes ( i.e. XY, YZ, XZ) and 
aligning the principle moments of inertia with the X, Y, and Z axes (Rohrbaugh, R. H. 
and Jurs, P. C., 1987).    The significance of this descriptor with regards to GJIC is that 
positions of methyl substitutions, which change the molecular shadow influence on GJIC 
(Upham, B. et al., 1996; Upham, B. L. et al., 1998).  This descriptor is also influential in 
describing the binding and transport of molecules as recently shown in a study 
conducted on numerous chemicals to explain estrogen receptor binding (Hong, H. et al., 
2002).   
 The third descriptor used in the QSTR for GJIC is Jurs-PNSA-1, the partial 
negative surface area.  This descriptor is a charged partial surface area descriptor that 
encodes spatial and electronic information that relates to the tendency of molecules to 
engage in polar interactions (Stanton, D. T. and Jurs, P. C., 1990).  With a negative 
coefficient, decreasing values of this descriptor results from decreasing molecular 
polarity for a molecule more or less likely to be moved through the gap junction of a cell 
(Equation 3.10).  This descriptor correlates with the spatial descriptor, density, which 
expresses transport behavior of a molecule (AccelrysSoftwareInc., 2005).  
 Two QSTRs were generated for previously developed TEFs and USEPA 
potential potencies (PPs) (Nisbet, I. C. and LaGoy, P. K., 1992; USEPA, 1993).  These 
two models were generated to determine the effectiveness of QSTRs to predict TEFs or 
PPs.  Equations 3.11 and 3.12 describe PPs and TEFs and contained only spatial 
descriptors.  Both of these equations contain the descriptor PMI-mag, the magnitude of 
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the principal moments of inertia about the principal axes of a molecule.  This descriptor 
evaluates the symmetry of the top of the molecule.   
 The QSTR describing potential potencies (equation 3.11) also contains a 
molecular volume descriptor (Vm).  This descriptor is a 3D spatial descriptor that 
defines the molecular volume inside the contact surface.  The molecular volume is 
calculated as a function of the molecules’ conformation and is related to binding and 
transport (AccelrysSoftwareInc., 2005).   
 TEFs are described by not only PMI-mag but also by a shape-electronic 
descriptor, Jurs-WNSA-3, a surface weighted charged partial surface area.  This 
descriptor refers to a negatively charged surface area and is highly correlated with the 
molecular area, another descriptor related to binding and transport.  The model for the 
PPs and for the TEFs showed a source of potential error because there were several 
observations that were the same (Figures 11and12).  The PPs and TEFs were order of 
magnitude estimates and resulted in generating the same estimate for chemicals of 
different size, shape, and activity.  This can result in a model that has poor predictive and 
explanatory power thus reinforcing the need for a better means to estimate toxicity 
factors.  Evaluating the relevant statistics for equations 11 and 12 reveals poor 
explanatory and predictive power (Table 5).  The lack-of-fit (LOF) scores as well as the 
sum of squared deviations of the dependent variable values from their mean (SD), for 
both equations, were high compared to the other equations (Table 5) indicating that the 
equations do not have much predictive power.   
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 QSTRs can be effective in rapidly assessing chemical toxicity solely from 
molecular structure.  However, not all QSTRs reliably assess toxicity.  In fact, the most 
meaningful QSTRs describe how variation in chemical structure relates to a specific 
response not overall toxicity.  This is demonstrated in the two developed QSTRs for 
TEFs and PPs (Figures 11 and 12).  TEFs and PPs refer to an overall toxicity and not to 
a specific toxic endpoint.  The order of magnitude estimates do not provide enough 
interpretation of the chemical attributes to make a toxicity estimate solely from these 
relationships.  The currently available TEFs for PAHs from Nisbet and Lagoy (1993) are 
order of magnitude estimates.  The TEFs predicted in this study reflect more precise 
estimates as they are made up of estimates of toxicity for specific toxic endpoints.     
 Improved predictions of toxicity for PAH compounds are possible if each 
compound is evaluated based on its ability to activate, initiate and/or promote cancer.  
TEF or PP values were estimated based on the QSTR predicted response from each 
bioassay.  A weighting factor was assigned to the appropriate toxic endpoint prediction 
for the PAHs ability to activate, initiate, and promote (Table 7) generating a TEFB or 
PPB relative to the toxicity of BAP.  An example of this concept is illustrated for 
chrysene in equation 3.13.  Chrysene, a complete carcinogen, activates detoxifying 
enzymes, is an initiator, and is shown to be a promoter of cancer. 
 
               TEFB (Chrysene) = 0.3(QSTR (EROD))                                              Eqn. 3.13 
    + 0.3 (QSTR (AMES)) + 0.4(QSTR (GJIC))   
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Therefore, each response is given an equal weight except the promotion response (0.4) 
where chrysene was shown to be a promoter and distant site tumors were observed.  This 
TEFB would still be an estimate of toxicity that is relative to BAP however; it would be 
based on specific knowledge of the chemical’s ability to act in each stage of 
carcinogenesis.  This would provide an improved estimate of toxicity over the currently 
available TEFs and PPs.  As QSTR models are improved and expanded the estimated 
toxic endpoint becomes more robust and reliable allowing for better predicted TEFs.     
 Shape-electronic descriptors were present in each of the QSTRs developed, 
indicating that these descriptors were effective in representing the toxicity of PAHs in 
the bioassays modeled.  Shape-electronic descriptors are a subset of spatial descriptors 
that symbolize the tendency of a molecule to engage in polar interactions.  Polar 
interactions are important in many processes of toxic action.  Polar and non-polar 
surface areas are commonly used to determine cell permeability.  Recently, modeling 
transport through the blood brain barrier was characterized using molecular flexibility, 
hydrophobicity, and polar surface areas (Winkler, D. A. and Burden, F. R., 2004).   
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Table 7.  QSTR predicted TEFs for selected PAHs. 
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CHAPTER IV 
RISK ASSESSMENT OF HARMFUL ALGAL BLOOMS: CHALLENGES AND 
PROGRESS IN ASSESSING TOXICITY 
 
Overview 
 
 There are six recognized poisoning syndromes that result from algal toxins 
affecting human health through their consumption of contaminated seafood or direct 
contact with bloom water or inhalation of aerosolized toxin.  Human health risk 
assessments (HHRAs) for harmful algal blooms (HABs) are hindered due to the lack of 
toxicity factors that describe the toxicological impact of the toxins based on exposure 
route.  A bioassay based reference dose (RfDB) for an inhalation exposure was 
developed for use in HHRAs.  The reference dose is the first step in assessing the risk to 
human health from in vitro cytotoxicity data rather than from shellfish bed closures.  The 
reference dose developed for PBTX-2 is based on several strains of Karenia brevis 
cultured under different salinities and temperatures.  A reference dose of 0.0571 mg/kg-
day dose was used in a HHRA to estimate the risk from inhaled aerosolized brevetoxin 
in a recreational setting.  The use of this reference dose showed that there was no 
significant non-carcinogenic risk from exposure to the brevetoxin in the exposure 
scenario examined herein. 
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Introduction 
 Varieties of harmful algal blooms (HABs) affect human and ecological health 
every year.  Algal blooms are reported in the waters of every U.S. coast and in many 
other parts of the world.  Recently, there has been an increase in the frequency and 
geographic occurrence of these HABs (Hallengraeff, G. M., 1993; Van Dolah, F. M., 
2000; Hallegraeff, G. M., 1993).  The increased incidence has magnified the need to 
assess impact to human and ecological health.  Currently, regulatory measures for the six 
recognized human poisoning syndromes are based mainly on epidemiologic data derived 
from poisoning incidents.  However, these data are seldom accurate and complete, and 
mainly restricted to acute toxicity.  Incident based data provide acute toxicity 
explanation, but to predict potential impact necessitates a more complete data set 
generated under controlled experimental conditions.  Improved assessment methods for 
HABs can then be used to develop appropriate regulatory measures.   
 An HHRA for brevetoxins is hampered by the lack of toxicity factors and 
measured exposure concentrations.  There are unidentified toxins (e.g Pfiesteria), in 
some cases, the indicators for effects and exposure are poorly defined, and there are no 
available reference doses or toxicity factors for these algal toxins.  The significant 
uncertainties in HHRAs currently include: unidentified toxins, lack of reference doses or 
toxicity factors, species and toxin variability, measured aerosol concentrations at points 
of exposure, and unknown environmental triggers causing the blooms.   
 Neurologic or neurotoxic shellfish poisoning (NSP) is caused by polyether 
brevetoxins produced by the unarmored dinoflagellate Karenia brevis.  The brevetoxins 
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are toxic to fish, marine mammals, birds and humans, but not to shellfish.  Until the year 
1993, neurologic shellfish poisoning was considered endemic only to the Gulf of Mexico 
and the east coast of Florida, where “red tides” had been reported as early as 1844 
(Pierce, R. H., 1986).  An unusual feature of Karenia brevis is the formation of toxic 
aerosols generated when wave action causes the release of toxin that then becomes 
aerosolized.  Asthma-like symptoms in humans can result upon exposure.  In 1987, a 
major Florida bloom event was dispersed by the Gulf Stream northward into North 
Carolina waters where it has since continued to be present.  In early 1993, more than 180 
human shellfish poisonings were reported from New Zealand caused by an organism 
similar to Karenia brevis.  It is likely that this was a member of the hidden plankton 
flora that was previously present in low concentrations.  This plankton flora then 
developed into bloom proportions triggered by unusual climatic conditions that can 
range from higher than usual rainfall to lower than usual water temperatures.  It has been 
hypothesized that this bloom was coincident with an El Niño event (Hallegraeff, G. M., 
1993). 
 The NSP toxins (PBTX) are tasteless, odorless, heat and acid stable, lipid-
soluble, cyclic polyether neurotoxins produced by the marine dinoflagellate Karenia 
brevis.  The molecular structure of the brevetoxins consists of 10 to 11 transfused rings 
with molecular weights are around 900 mass units (Figure 13).  Ten brevetoxins have 
been isolated and identified from field blooms and Karenia brevis cultures (Benson, J. 
M. et al., 1999). These brevetoxins show specific binding to site-5 of voltage-sensitive 
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Na+ channels leading to channel activation at normal resting potential causing toxic 
effects (Cembella, A. D. et al., 1995).   
 Karenia brevis produces a lipophilic toxin (brevetoxin; PBTX) that alters the 
normal function of excitable cell membranes.  This toxic action is accomplished by 
inducing persistent activation of sodium channels (Catterall, W. A. and Risk, M., 1981; 
Baden, D. G., 1989).  Brevetoxins are depolarizing substances that open voltage gated 
sodium (Na+) ion channels in cell walls.  This opening of the channel alters the 
membrane properties of excitable cell types to enhance the inward flow of Na+ ions into 
the cell (Fleming, L. E. et al., 1999). The toxin appears to produce its symptoms by 
transforming fast sodium channels into slower ones, resulting in persistent activation and 
repetitive firing (Watters, M. R., 1995). 
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Type 1 (A) brevetoxins: PBTX-1 R = CH2C(=CH2)CHO 
 PBTX-7 R=CH2C(=CH2)CH2OH
 PBTX-10 R=CH2CH(CH3)CH2OH
   
 
 
Type 2 (B) brevetoxins: PBTX-2 R = CH2C(=CH2)CHO 
 oxidized PBTX-2 R=CH2C(=CH2)COOH 
 PBTX-3 R=CH2C(=CH2)CH2OH 
 PBTX-8 R=CH2COCH2Cl 
 PBTX-9 R=CH2CH(CH3)CH2OH 
 PBTX-5 the K-ring acetate of PBTX-2 
 PBTX-6 the H-ring epoxide of PBTX-2
   
   
Figure 13.  Brevetoxin Structures (Adapted from Hua, et al, 1995) 
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Conformational analysis revealed that the unsaturated H-ring of brevetoxin B 
(Figure 13) favors the boat-chair conformation, as does the saturated G-ring of 
brevetoxin A (Figure 13) (Plakas, S. M. et al., 2002; Poli, M. A. et al., 2000; Radwan, F. 
F. and Ramsdell, J. S., 2006; Rein, K. S. et al., 1994).  After reduction has occurred, the 
H-ring of brevetoxin B shifts to a crown conformation.  This subtle change in 
conformational preference induces a significant change in the overall shape of the 
molecule, which is believed to be responsible for the loss of binding affinity and toxicity 
(Rein, K. S. et al., 1994). 
 Respiratory problems associated with the inhalation of aerosolized brevetoxins 
are believed to be due in part to opening of sodium channels.  In sheep, bronchospasm 
could be blocked by atropine while there appears to be a role for mast cells.  In sheep the 
bronchospasm could be effectively blocked by cromolyn, a mast cell stabilizer 
preventing histamine release and chlorpheniramine, a first generation antihistamine 
(Abraham, W. M. et al., 2005b).  It has been reported that brevetoxin could combine 
with a separate site on the gates of the sodium channel, causing the release of 
neurotransmitters from autonomic nerve endings (Fleming, L. E. et al., 1999).  In 
particular, this can release acetylcholine, leading to smooth tracheal contraction, as well 
as massive mast cell degranulation (Abraham, W. M. et al., 2005; Fleming, L. E. et al., 
1999; Fleming, L. E. et al., 2005).Brevetoxins are periodically responsible for marine 
animal mortalities, non-fatal human effects and occasional economic hardships.  Some 
of the known human health effects include respiratory distress upon exposures to 
seawater aerosols containing brevetoxins and seafood poisoning (neurotoxic seafood 
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poisoning; NSP) after consumption of brevetoxin-contaminated shellfish (Aune, T., 
1997; Pierce, R. H., 1986).  Although these health effects have been observed, the lack 
of brevetoxin toxicity factors prevents generating reliable HHRAs.  The current 
regulations for states along the Gulf of Mexico is based on shellfish bed closures at 
concentrations of 5000 Karenia brevis cell per liter, reopening is based on shellfish 
PBTX of <80 µg/100 g. 
 A bioassay based reference dose for brevetoxins was used to generate data for a 
HHRA on these HABs.  The hypothesis is that brevetoxin toxicity can be estimated 
using a bioassay based reference dose (RfDB) for the purpose of an initial attempt to 
evaluate human health risk.  The objectives of this study were to culture algal species 
that are common to the Gulf of Mexico in different salinities and temperatures to 
determine how stress affects toxin production.  Secondly, these cultures were extracted 
and there toxicity was evaluated using an in vitro cytotoxicity bioassay.  Finally, the 
dose response curves from the bioassay were used to develop bioassay based reference 
doses to be used in an initial human health risk assessment.  The results of the initial 
human health risk assessment are also presented herein.   
Materials and Methods 
Experimental Approach 
 Several species of HABs were grown and maintained for harvesting to be used in 
the toxicity assays.  Each species was maintained at different salinities and temperatures 
to examine the effects of temperature and salinity on toxin production.  Each species was 
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harvested and counted to estimate toxicity production.  These species were used in a 
traditional cytotoxicity assay, at different concentrations to determine there toxicity.  
Three controls were used in this assay to determine the cytotoxicity of the brevetoxins 
produced by these species.  The controls used are as follows:  cells only, solvent only 
(ethanol at less than 0.5%), and activator control (oubain and veratridine, O/V).  From 
this data, a reference dose was determined for PBTX-2 to be used in HHRAs.  A HHRA 
was developed to estimate the effects of inhaled brevetoxin on human in a recreational 
setting. 
Cell Culture 
 Mouse neuroblastoma cells (N2A) (ATCC-CCL131) were grown and maintained 
in Dulbecco’s Modified Eagle Medium (DMEM) containing 10% fetal bovine serum 
(Sigma Co., St. Louis, MO).  Streptomycin (Sigma Co., St. Louis, MO.) and Penicillin 
(Sigma Co., St. Louis, MO.) were also added at 50µg and 50 units per milliliter.  
Cultures were maintained in an incubator at 37°C with humidified 5% CO2 and 95% air 
atmosphere.  Cells were harvested for the cytotoxicity assay with a solution of Trypsin 
(5%) and PBS.  The cells were then seeded in a 96-well plate (Costar, Cambridge, MA) 
at a density of 30,000 cells per well in 100µl of growth medium.  Cells were incubated 
for 24 hours in an incubator exposed to 5% CO2 before dosing.   
Algal Culture 
 Seven clonal isolates of Karenia brevis, five from the Texas coast and two from 
Florida (Table 8), were maintained in L1 medium (Guillard and Hargraves, 1993) at 22º 
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C,  70 ± 2  mol photons m-2 s-1 on 12:12h light:dark cycle, and salinity of 30 ppt.  These 
cultures were grown in the laboratory of Dr. Campbell of the Texas A&M University’s 
Department of Oceanography.  Prior to cytotoxicity assays, all clones were acclimated to 
a range of growth conditions for at least ten generations gradually (at increments of  2 oC 
; 2 salinity units) to experimental conditions (20 and 25 oC  ; salinities of 27 and 35).  
For each growth condition, glass culture flasks (100 mL) were inoculated with 
approximately 10 mL of dense, acclimated culture and allowed to grow until mid-
stationary phase.  All cultures were harvested within 17-20 days to prevent variable 
toxicity due to external variables (Pierce, R. et al., 2001).  Cell pellets from each culture 
were harvested by gentle centrifugation 3200 g / 5 min / 4º C, to create a soft pellet of 
cells.  Supernatant was then aspirated and the pellet was extracted immediately.  The 
supernatant volume was centrifuged at 3200rpm for approximately 5 minutes.  The 
supernatant was decanted to 5ml and the pellet re-suspended and deposited in its 
respective culture bottle.  The concentrated cell solution was then extracted using 3 
washes of equal parts ethyl acetate.  The extracted volume of ethyl acetate was dried 
down in the roto-evaporator unit, transferred to 4ml or 8ml amber glass vials via a 
pipette, and dried down manually with nitrogen.  Cultures were resuspended in ethanol 
for cytotoxicity testing. 
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Table 8. Karenia brevis clones at Texas A&M University. 
 
Clone Collection location and date Origin of isolate 
SP1 Brownsville, TX (Fall, 1999) T. Villareal 
SP2 Brownsville, TX (Fall, 1999) T. Villareal 
TSP3 Brownsville, TX (Fall, 1999) T. Villareal 
NTSP3 Brownsville, TX (variant) C. Hyatt 
TXB3 Brownsville, TX (Fall, 1999) K. Steidinger 
TXB4 Brownsville, TX (Fall, 1999) K. Steidinger 
CCMP2228 Sarasota, Florida (August, 2001) C. Higham 
CCMP 718 St. John’s Pass (1953) W.B. Wilson 
 
 
 
MTT Cytotoxicity Assay 
 Cultured wells received 10µl of each sample at concentrations of 8, 4, and 2 
µg/ml.  Additionally, 10µl of 10mM Ouabain (Sigma Co., St. Louis, MO.) and 10µl of  
1mM Veratridine, pH 2 (Sigma Co., St. Louis, MO.) were added to each well.  A cell 
control, solvent control, and ouabain/veratridine control (O/V) were run for each 
experiment.  Each concentration and control was run with 8 replicates.  Cultures were 
then incubated for an additional 24 hours following treatment in an incubator exposed to 
5% CO2 before running the assay.  MTT ( 3-[4,5-dimethylthiozol-2-yl]-2,5 –
triphenyltetrazolium) was prepared as a 2.5mg/ml stock solution in PBS, pH 7.4 and 
stored at 4°C until use.  Following the incubation with samples, the media was removed 
and 50µl of a 1:4 dilution of MTT and growth media was added to each well.  Cultures 
were incubated for 30 minutes at 37°C in 5% CO2.  Medium was then removed and 
100µl of dimethyl-sulfoxide (DMSO) was added to each well.  The plates were 
immediately read on a Biotek Synergy HT Plate Reader (Biotek Instruments Inc., 
   91
Winooski, VT) at a wavelength of 570nm.  Results from each treatment were compared 
using a one-way ANOVA.   
Chemical Analysis 
 Each sample and a set of 9 brevetoxin standards (Brevenal, PBTX-1, 2, 3, 6, 7, 9, 
11, PBTX-ca) samples were analyzed using a Matrix-assisted laser desorption/ionization 
time-of-flight (MALDI-TOF) instrument.  MALDI-TOF spectra were recorded in 
reflected ion mode with an Applied Biosystems Voyager DE-STR mass spectrometer 
(ABI, Framingham, MA).  Positive ions were generated by using a nitrogen laser pulse 
(λ = 337 nm, 20 Hz) and accelerated under 20 kV using delayed extraction (175 ns) 
before entering the time-of-flight mass spectrometer.  Laser strength was adjusted to 
provide minimal fragmentation and optimal signal-to-noise ratio.  An average of 200 
laser shots was used for each spectrum, and data were processed with the accompanying 
Voyager software package.  A dried droplet procedure was used with 2,4,6-
trihydroxyacetophenone (THAP).  A 1:1:1 mixture of analyte, a 10 mg/mL THAP 
solution in methanol, and a 1 mg/ml solution of LiCl (to assist with ionization) was 
spotted in 1µL aliquots on top of a stainless steal plate.  The most abundant ions 
observed for Brevetoxin B (PBTX-2) and Brevetoxin A (PBTX-3) correspond to 
(M+Li)+ at m/z 901 and m/z 903, respectively. 
 Samples were also analyzed via LC/MS.  The instrument was optimized using a 
standard solution of the eight brevetoxins and brevenal used in this study.  The APCI 
ionization technique was used to analyze the samples by both single ion monitoring, for 
increased sensitivity and by collision induced dissociation, for structure determination.   
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Results 
Cytotoxicity Assay 
 Toxicity assays performed on algal cultures at combinations of two temperatures 
and two salinities yielded data from which a reference dose value were determined.  This 
reference dose was used to generate an initial HHRA for the inhalation exposure to 
brevetoxin.  Cultures were determined to be toxic if their response fell below the 
activator response as indicated by the bold line on each figure.  Cultures of Karenia 
brevis raised at 25°C and either 35 ppt or 27 ppt salinity demonstrated significant 
changes in toxicity as measured by the mouse neuroblastoma cytotoxicity assay.  The 
cytotoxicity assay revealed that only SP1, NTSPE, and TXB3 (grown at 25°C and 
27ppt) resulted in a toxic response (Figure 14).  A dose response curve for SP1, NTSP3 
and TXB3 (25°C, 27 ppt) resulted with the most toxic response being at 8 µg/ml that 
decreased proportionally (Figure 14).  At 25°C and 35ppt, SP2 and NTSP3 elicited a 
toxic response at all concentrations tested.  However, TXB3 and 718 were toxic at 8 and 
4 µg/ml and a dose response was observed for both species (Figure 15).  The dose 
response curves for the species at 25°C and 35ppt were not as pronounced as was seen at 
other temperature and salinity.  For example, the higher salinity (35 ppt) resulted in 
greater toxicity at 20°C.    
 
 
 
 
   93
0
0.1
0.2
0.3
0.4
0.5
0.6
Ce
lls
Eth
an
ol O/
V
71
8
SP
1
SP
2
TS
P3
NT
SP
3
TX
B3
TX
B4
A
bs
or
ba
nc
e
8 µg/ml
4 µg/ml
2 µg/ml
 
Figure 14.  Cytotoxicity of Karenia brevis species at 25°C and 27ppt. 
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 Figure 15.  Cytotoxicity of Karenia brevis species at 25°C and 35ppt. 
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For cultures grown at 20°C and 27ppt, three species showed significant toxicity 
to the N2A cells.  Cultures 718, SP2, NTSP3 and TXB3 all showed 30-50% more 
toxicity than the positive control response of O/V (Figure 16).  A dose response curve 
was observed for TXB4 at this temperature and salinity.  At 20°C and 35ppt, there was 
significant toxic response when compared to controls from 718, SP1, NTSP3 and TXB4.  
Also, SP2 showed toxic responses for 8 and 4 µg/ml and the toxicity at 2µg/ml was 
slightly less but within the standard error (Figure 17).  Dose response curves were 
determined for NTSP3 and TXB4 at this temperature and salinity.   
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Figure 16.  Cytotoxicity of Karenia brevis species at 20°C and 27ppt. 
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 Figure 17.  Cytotoxicity of Karenia brevis species at 20°C and 35ppt. 
 
 
At 25°C the toxicity of species of Karenia brevis was more obvious at 35 ppt.  
Species 718 and SP2 showed toxic responses that were not seen in cultures grown at 27 
ppt.  Similarly, for 20°C the toxic response of species was more pronounced at 35 ppt for 
718 and SP1.  SP1 showed significant increase in toxicity when compared to cultures 
grown at 27 ppt.  Interestingly, at this salinity (35ppt) NTSP3, TXB3, and TXB4 showed 
reduced toxicity when compared to cultures grown at 27ppt.  The 718 species showed 
toxic responses at two or more doses at all temperatures and salinities tested in this assay 
except at 25°C and 27ppt.  NTSP3 produced a toxic response at all temperatures and 
salinities tested in this assay.  SP1 elicited the most toxic response at 20°C and 35ppt, 
however there was not an obvious pattern for toxicity based on temperature or salinity 
for this species.  Similarly, SP2 elicited the most toxic response at 25°C and 35ppt, but 
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there was not an obvious correlation of toxicity with any one temperature or salinity.  
TXB3 showed the most toxic responses at 20 and 25°C when the salinity was held at 
27ppt.  This same species at higher salinity (35ppt) did not produce as significant a 
response.  Similarly, for TXB4 there was a toxic response observed when the 
temperature was held at 20°C and varying salinities, while at 25°C there was not a toxic 
response observed at either salinity tested.  TSP3 was the only species that did not elicit 
a toxic response at any of the salinities or temperatures tested. 
Chemical Analysis 
 The chemical analyses preformed in this study determined which species of 
brevetoxin were present in each of the cultures tested.  The MALDI-TOF technique 
detected brevetoxin species at femtamole quantities of molecules.  Although nine 
standard brevetoxins were scanned for in each of the cultured species only one 
brevetoxin was identified in the cultures, PBTX-2 (data not shown), using the MALDI-
TOF method.  There were not any other forms of brevetoxin detected.  Nor was 
brevenal, the brevetoxin inhibitor, detected in the cultured species.  PBTX-2 was 
detected only for the TXB4 culture at all temperatures and salinities.  NTSP3 (20°C and 
both 27 and 35ppt) had detectable amounts of PBTX-2 present.  SP2 at 20°C and 27ppt 
had detectable amounts of PBTX-2, however other variations of salinity and temperature 
did not yield any other species of brevetoxin or brevenal detectable in this method of 
analysis.  The chemical analyses did not correspond well with the observed cytotoxicity 
suggesting that PBTX was not the only contributor to overall toxicity.   
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 Data from the LC/MS method detected several other brevetoxin species present 
in the same cultures as were tested by the MALDI-TOF method as seen in Table 10.  
PBTX- 1, 2, 3, 7, 11, and brevenal were all detected in the cultures grown at varied 
temperature and salinity.  PBTX- 6, 9, and –ca were not detected in any of the cultures 
regardless of temperature or salinity.  Brevenal, the brevetoxin inhibitor was detected in 
all the cultures except SP1 grown at 25°C and 27ppt, SP2 and TSP3 grown at 20°C and 
27ppt, and SP2 grown at 20°C and 35ppt.   
Risk Assessment 
 A reference dose was calculated using the bioassay based no-observable-adverse-
effects-level (NOAEL) from cytotoxicity assay (2µg/ml) to calculate the risk due to 
inhalation of toxin aerosols in the beach environment.  The reference dose is adjusted 
using body weight and inhalation rate.  A reference dose was calculated based on the 
following equation: 
 
RfDB-Inh = NOAEL / (UF1 * UF2 * UF3 * MF)                          Eqn 4.1 
 
where NOAEL was 2000 mg/m3, the uncertainty factor UF1 is 10 for variations in 
population sensitivities, UF2 is 10 for extrapolation from animals to humans, UF3 is 10 
for using a subchronic NOAEL instead of a chronic NOAEL, and MF was a modifying 
factor (10) based on a qualitative professional assessment of the uncertainties in this 
study.  The scenario used in the risk assessment was a recreational exposure for adults 
and children.  The exposure factors used to calculate the risk are listed in Table 9.  The 
   98
concentration of PBTX-2 in air was assumed to be 2.7E-5 mg /m3 based on work 
reported by Cheng et. al (2005) which evaluated particle size distribution, concentration 
and toxic profile for PBTX in a beach environment.  This value was the highest daily 
mean observed during the previously mentioned study (Cheng, Y. S. et al., 2005).  The 
risk was calculated using the following equation: 
 
Risk =  [ EPC * IR *ET * EF * ED * FC/ ( BW * ATNC)] / RfDB-Inh                   Eqn 4.2 
 
where EPC is the expected concentration, IR is the ingestion rate, ET is the exposure 
time, ED is the exposure duration, FC is the fraction from the contaminated source, BW 
is the body weight, ATNC is the averaging time from non-carcinogens, and RfDB-Inh is the 
bioassay based reference dose for inhalation developed in this study (Table 9).   
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Table 9. Exposure factors used in HHRA. 
 
Adult 
Abbreviation Factor Value Units 
IR Inhalation Rate 0.833 m3/hour 
EF Exposure Frequency 56 days/year 
ED Exposure Duration 30 yr 
BW Body Weight 70 kg 
ATNC Averaging Time - Non-carcinogen 10950 days 
FC Fraction from Contaminated Source 1 unitless 
ET Exposure Time 6 hours/day 
Child 
Abbreviation Factor Value Units 
IR Inhalation Rate 0.5 m3/hour 
EF Exposure Frequency 56 days/year 
ED Exposure Duration 6 yr 
BW Body Weight 15 kg 
ATNC Averaging Time - Non-carcinogen 2190 days 
FC Fraction from Contaminated Source 1 unitless 
ET Exposure Time 6 hours/day 
 
Discussion 
Cytotoxicity Assays 
 Each of the tested clones has been reported to be capable of producing different 
forms of brevetoxin and are found in typical algal blooms in the Gulf of Mexico (Baden, 
D. G., 1989).  Each clone was evaluated in the bioassay and toxin profiles were 
examined.  It is known that brevetoxins exert their effects by interaction with voltage 
sensitive sodium channels in excitable membranes (Dickey, R. et al., 1999; Manger, R. 
L. et al., 1995; Manger, R. L. et al., 1993).  The brevetoxins responsible for NSP bind to 
a certain class of biological receptors namely to voltage-sensitive Na+ channels.  This 
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highly specific interaction with naturally occurring receptors forms the basis of this 
bioassay.  Detection is based on the functional activity of the toxin rather than on 
recognition of a structural component.  Moreover, the affinity of a toxin for its receptor 
is directly proportional to its toxic potency.  Thus, for a mixture of toxins (i.e. PBTX-2 
and PBTX-3), a receptor-based assay will yield a response representative of the 
integrated potencies of those toxins present (Cembella, A. D. et al., 1995).  This 
neuroblastoma cell assay cannot distinguish between individual brevetoxins (Hua, Y. et 
al., 1995).  Any modification to a toxin molecule that would alter its ability to bind to the 
receptor and thus its detection in a receptor-based assay, compromises its ability to elicit 
a toxic response.  Another consideration is the toxicity of other components in the 
cultures that could cause cytotoxicity.  The results from the bioassay analysis showed 
some toxicity even when brevetoxin was not detected in the culture (i.e. TXB3, Figures 
14, 15, 16).  Therefore, some other component caused cytotoxicity in the cells.   
 At a temperature of 25°C toxicity was observed in cultures SP1, NTSP3, and 
TXB4  when the salinity was 27ppt (Figures 14 and 15).  When the salinity was increase 
to 35ppt at this same temperature those cultures (SP1, NTSP3, and TXB4) showed a 
decrease in toxicity.  However, for the SP2 culture, toxicity increased at the higher 
salinity of 35ppt.  These results indicate that for the the species SP1, NTSP3, and TXB4 
the brevetoxin produced by these cultures was less at 35ppt.  For the SP2 culture, the 
increase in toxicity at 35 ppt would suggest that an increase in salinity could affect 
strains of Karenia brevis differently.  Therefore, in a bloom of mixed cultures there 
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could be different interactions due to temperature and salinity that affect the overall 
toxicity.    
 For cultures grown at 20°C, the species 718, SP1, and TXB4 showed an increase 
in toxicity at 35ppt when compared to 27ppt (Figure16 and 17).  At this temperature 
(20°C) there was more toxicity observed for cultures SP2, NTSP3, and TXB3 at 27ppt.  
These results indicate that the effects of temperature and salinity can be different 
depending on the different species of Karenia brevis.  The toxic effects of the same 
cultures were different at the temperatures and salinities in this study.  For the same 
cultures (SP1, NTSP3, and TXB4) at 25°C the toxicity decreased as salinity increased.  
However, at 20°C, as salinity increased the toxic response increased in some cases (718, 
SP1, and TXB4).  This would indicate a definite relationship between temperature and 
salinity that affects the amount of toxin produced.  Other researchers have shown 
differential physiologic effects with many of the natural toxins and their derivatives.  
Researchers have hypothesized that metabolism or modification of toxin structure 
modulates both the specific toxicity and potentially the molecular mechanism of toxic 
action (Baden, D. G. et al., 2005).  Similarly, the salinity and temperature could affect 
the specific toxicity or the mechanism of toxic action as seen in this study.   
 This assay was also run using two additional cell lines; Clone 9 rat liver cells 
(ATCC, CRL-1439, passage 17) and a human neuroblastoma cell line (ATCC, CRL-
2266, passage 23).  These two cell lines showed no toxic response to any of the cultures 
tested (data not shown).  The Clone 9 cell line and the human neuroblastoma cell lines 
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may not have sodium channels that are affected in the same manner as the mouse 
neuroblastoma cell line.  These toxins may not affect these two cell lines or the response 
was too low to detect given the sensitivity of the assay.   
 The cytotoxicity results were used to determine the NOAEL for those cultures 
with demonstrated toxic effects.  Nine brevetoxin standards (PBTX-1, 2, 3, 6, 7, 9, 11, -
ca, and brevenal) where analyzed for in each extracted culture.  A bioassay based 
reference dose for PBTX-2, the brevetoxin species detected in all of the cultures, to be 
used in human health risk assessment was developed using a NOAEL of 2µg toxin/ml.  
The NOAEL was derived from the results of the cytotoxicity assay dose response curves 
in this study.  HHRAs for non-carcinogens compare environmental exposure 
concentrations to a reference dose that is based on the NOAEL.   
Chemical Analysis 
 Analytical techniques for the identification of the brevetoxins and determining 
quantify the toxins are limited by availability of standards and the need for advanced 
analytical methods.  The MALDI-TOF method only identified PBTX-2 in some of the 
cultures examined.  Initial results using the LC/MS method revealed all except three 
(PBTX-6, -9, -ca) of the nine brevetoxin standards looked for to be present in some or all 
of the cultures (Table 10).  The brevetoxins identified for each of the algal species and 
their respective culture conditions are summarized in Table 10.  No distinct pattern of 
brevetoxin production based on temperature and salinity of these cultures was revealed.  
Temperature and salinity had no effect of the production of PBTX-6, -9, and –ca which 
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were not detected in any of the cultures (Table 10).  Similarly, temperature and salinity 
had no effect on the production of PBTX-2, one of the toxins found in all the cultures 
tested.  Brevenal was detected in all except four of the cultures tested (Table 10), yet 
there was observed toxicity in the cytotoxicity assay in these four cultures (Figures 14-
17).  Brevenal is supposed to be a natural inhibitor of brevetoxins.  That toxicity was 
observed in the presence of this blocking agent indicates that there is another compound 
or mechanism that is also eliciting toxicity in these cultures.  Initial results using this 
LC/MS method also revealed two unidentified peaks that are being further examined 
(data not shown).   
Risk Assessment 
 Karenia brevis produces brevetoxins that are readily aerosolized by wave action 
releasing the toxins into the air.  The most likely immediate route of exposure for 
humans is inhalation.  Similarities in the mechanism of toxic action of NSP and the 
inhalation of aerosolized brevetoxin justify the bioassay based reference dose for 
inhalation.  A reference dose was developed for an inhalation scenario to evaluate the 
risk to humans from the inhalation of aerosolized brevetoxins.  The reference dose for 
PBTX-2 aerosols was 0.0571 mg / kg-day, derived from the NOAEL divided by the 
appropriate uncertainty and modifying factors.  An estimated aerosol concentration of 
concentration of 2.7E-5 mg / m3 was used based on work done by Cheng et.al (2005).  
For an adult in a recreational setting the inhalation exposure scenario risk was estimated 
to be 5.17E-6 while that for a child was 1.45E-5.  Both estimates are well below the  
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Table 10.  Brevetoxin species identified by LC/MS in Karenia brevis cultures at various 
temperatures and salinities. 
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hazard index of 1.0 indicating that no adverse effects to humans at the concentration 
encountered in the evaluated scenario.  While this attempt at calculating the human 
health risk from exposures to aerosolized brevetoxin shows no risk at the concentration 
tested here, this is a first attempt at calculating a reference dose for these toxins.  The 
reference dose is traditionally calculated from a chronic animal study but the US 
Environmental Protection Agency (USEPA) has made provisions in the Risk 
Assessment Guidelines for Superfund (RAGS) to account for reference doses calculated 
from acute testing (USEPA, 1989).  The bioassay based reference dose for inhalation 
developed in this study does provide a first step at evaluating human health effects from 
something other than the current bed closure or tissue concentration guidelines set up for 
the ingestion route of exposure.   
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CHAPTER V 
CONCLUSIONS 
 By comparing the response of single PAH compounds and binary mixtures of 
PAHs, some insight was gained into how the structure of the compound can affect the 
carcinogenic process.  Structural differences can influence the carcinogenicity by simple 
effects on cellular uptake to metabolism and binding with critical proteins in the cell.  
We observed results that were not expected in some instances based on the bay region 
structure of some of the compounds.  Similarly, it was determined that compounds in 
mixtures affect each other producing a less than additive response (i.e. BAP mixed with 
5-methylchrysene); although additivity is a common assumption in the practice of risk 
assessment.  These responses reveal highly complex interactions that complicate 
predicting toxicity of PAHs or PAH mixtures. 
 Attempts to define toxicity of PAHs and PAH mixtures relative to BAP have 
been complicated by the fact that some carcinogenic PAHs are capable of both initiating 
and promoting tumors (ATSDR, 1990a).  Benzanthracene, chrysene, and BAP are 
reported to both initiate and promote (ATSDR, 1996).  The capability of these 
compounds to act via a distinct pathway to produce cancer results adds a great deal of 
uncertainty when attempting to predict toxicity based solely on responses in biological 
systems.  For this reason, the focus of this research was on three different assays each 
specific to a part of the carcinogenic process.  By evaluating a chemical’s response in 
each assay, an estimate of toxicity can be based on the observed response in each 
bioassay.  Taking into consideration the response of a chemical in each step of the 
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carcinogenic process (i.e. activation, initiation, and promotion), the mechanism, and 
toxic action of each chemical can be approximated.  Together these responses could be 
used to develop a bioassay based toxicity factor. 
 The lack of previous success in using a ranking system like TEFs or PPB for 
carcinogenic risk assessment of PAHs may be due to the complexity of behaviors 
exhibited among PAHs.  Success with the use of TEFs for dioxin-like compounds is due 
in part to toxicity being caused by a single, well-defined endpoint of AhR affinity.  The 
toxicity of PAHs and PAH mixtures may best be predicted by deriving a TEF or PPB    
from bioassays that measure specific toxic endpoints of the carcinogenic process while 
taking into consideration relevant physiochemical properties as well as structural 
properties of these compounds.  This study makes such estimates for PAHs using QSTR 
models that incorporate toxic responses for activation, initiation, and promotion stages of 
carcinogenesis, as well as structural properties of the compounds.  The predicted TEFs in 
this study provided a more precise estimate for PAH toxicity because they are based on 
specific toxic endpoints and are not order of magnitude estimates.  Using bioassay data 
and physiochemical properties to build QSTRs for classes of compounds which lack 
sufficient toxicity data will allow for more comprehensive risk assessments to be 
completed.  This method also reduces the time and expense of laboratory experiments 
for all the members of a class of chemicals. 
 This study developed QSTRs for three bioassays relating to specific endpoints 
important in the carcinogenic process for PAHs.  Application of QSTRs for assessing 
toxicity in a variety of bioassays can provide a reliable estimate of dose ranges for 
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animal testing and for toxicity factors for human health risk assessment.  QSTRs can 
also be used to prioritize costly and time intensive experimentation by predicting those 
compounds most likely to cause adverse effects.  There are limits to this approach for 
predicting toxicity from structure activity relationships.  It is important to train a QSAR 
model with chemicals within the same family and realize that the predictive power can 
only be applied within the family.  Also important is the quantity and diversity of the 
data used to create the model.  As much data as is available for each toxic endpoint 
should be used from as many compounds as possible from within the family.  The 
addition of more data to the training set for each bioassay will increase the explanatory 
and predictive power of each model.  Realizing the limitations of this procedure and 
carefully designing and training, the models can result in a robust QSTR that can lead to 
a more effective way to estimate toxicity and predict toxic response.  Using QSTRs 
developed from experimental data in this study allowed for a bioassay based TEF 
prediction.   
 Until this study, there has been insufficient data on which to base a human health 
risk assessment for brevetoxin exposure through an inhalation pathway.  Current risk 
management along the coasts of the Gulf of Mexico, is based on shellfish bed closures at 
5000 K. brevis  cells / liter with reopening based on determination of PBTX in shellfish 
at <80 µg/100 g.  Methods to develop a toxicity factor for these toxins were necessary to 
provide the basis of a risk assessment for brevetoxins.  Cell based detection methods for 
brevetoxins similar to the one used in this study provide a convenient method to evaluate 
biological activity of algal toxins.  Although in vitro methods cannot replace entirely the 
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data derived from animal studies, these methods do offer the potential to reduce cost, 
time, and the reliance upon animal testing.  This study employed a widely used 
cytotoxicity assay to predict an initial toxicity factor for one of the most prevalent forms 
of brevetoxin (PBTx-2).  The reference dose developed is a first attempt that provides a 
starting point for predicting human health effects from aerosolized brevetoxins.   
 Effects of the various exposure routes on humans are difficult to assess because 
toxicity data for brevetoxins are limited.  There are some acute studies in mice and data 
from poisoning cases in humans and (marine) mammals that are available but data on 
acute dermal and inhalation studies are lacking.  In addition, analytical reference 
materials are important to further develop and improve the analytical methodology and 
to allow analytical quality assurance.  Currently, varieties of obstacles stand in the way 
of reliable assessment of brevetoxin occurrence and exposure and thus the establishment 
of meaningful regulations.  In this study a bioassay based RfD was developed for PBTX-
2 and an initial HHRA was done to estimate the risk associated with exposure to inhaled 
aerosolized brevetoxin.  The developed RfD was used to calculate a non-carcinogenic 
risk for adults and children in a recreational scenario.  Using the developed RfD, the 
result observed was that there was no risk due to the inhaled aerosolized brevetoxin for 
the concentration used in this scenario.  This RfD was a bioassay based reference dose 
however, it provides an initial estimate to complete a HHRA. 
Risk assessment in general is a science that can be improved upon for many 
classes of chemicals.  Chemical analysis, bioassays, and QSARs can be used to improve 
the reliability and reduce the uncertainty in a risk assessment.  The combination of these 
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techniques to develop improved methods of toxicity assessment is a promising avenue 
for those classes of chemicals that are currently lacking sufficient toxicity data. 
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APPENDIX A 
 
 
GJIC Statistical Analysis 
 
Error             
  10uM 5uM 2uM 1uM 0.5uM DMSO 
5-MethylChrysene 0.002926 0.003118 0.003048 0.003722 0.004146 0.004659
Anthracene 0.007044 0.01282 0.009483 0.008985 0.005957 0.004659
Benz(a)anthracene 0.00389 0.007859 0.006742 0.00235 0.003743 0.004659
BAP 0.001696 0.003048 0.005957 0.01282 0.007235 0.004659
Chrysene 0.003838 0.00643 0.004511 0.000972 0.002487 0.004659
Phenanthrene 0.01143 0.007235 0.003582 0.00238 0.002406 0.004659
 
 
Error             
  10uM 5uM 2uM 1uM 0.5uM DMSO
BAP(10uM)/Chrysene 0.0137 0.0119 0.0161 0.01421 0.0045 0.0081
Chrysene(10uM)/BAP 0.011 0.01266 0.008 0.00374 0.00309 0.0081
BAP(10uM)/5-
Methylchrysene 0.0056 0.00159 0.0013 0.00453 0.00794 0.0081
5-
Methylchrysene(10uM)/BAP 0.0026 0.00187 0.0005 0.00105 0.00284 0.0081
Chrysene 0.0016 0.00132 0.0045 0.00794 0.01421 0.0081
5-MethylChrysene 0.011 0.01266 0.008 0.00374 0.00453 0.0081
BAP 0.0011 0.00284 0.0081 0.01421 0.0045 0.0081
 
 
EROD Statistics 
BAP 
  
Mean 436.4652
Standard Error 8.930544
Median 447.56
Mode #N/A 
Standard Deviation 65.62583
Sample Variance 4306.749
Kurtosis -0.49572
Skewness -0.37711
Range 255.51
Minimum 306.14
Maximum 561.65
Sum 23569.12
Count 54
Largest(1) 561.65
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Smallest(1) 306.14
Confidence 
Level(95.0%) 17.9124
 
Phen 
  
Mean 417.9332
Standard Error 6.35214
Median 404.01
Mode #N/A 
Standard Deviation 44.91641
Sample Variance 2017.484
Kurtosis -0.00619
Skewness 1.01274
Range 164.69
Minimum 364.58
Maximum 529.27
Sum 20896.66
Count 50
Largest(1) 529.27
Smallest(1) 364.58
Confidence 
Level(95.0%) 12.7651
 
5-MC 
  
Mean 369.1677
Standard Error 7.208234
Median 372.04
Mode #N/A 
Standard Deviation 42.64448
Sample Variance 1818.552
Kurtosis -0.89621
Skewness 0.017192
Range 156.46
Minimum 311.08
Maximum 467.54
Sum 12920.87
Count 35
Largest(1) 467.54
Smallest(1) 311.08
Confidence 
Level(95.0%) 14.64889
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DMSO 
  
Mean 314.585
Standard Error 4.947319
Median 301.69
Mode #N/A 
Standard Deviation 32.06229
Sample Variance 1027.99
Kurtosis -0.39328
Skewness 0.926212
Range 116.31
Minimum 275.16
Maximum 391.47
Sum 13212.57
Count 42
Largest(1) 391.47
Smallest(1) 275.16
Confidence 
Level(95.0%) 9.991313
 
 
 
Anova: Single 
Factor       
       
SUMMARY       
Groups Count Sum Average Variance   
Column 1 6 2322 387.0641 3876.4   
Column 2 6 1502 250.3554 9.7E-28   
       
       
ANOVA       
Source of Variation SS df MS F P-value F crit 
Between Groups 56067.77 1 56067.77 28.9277 0.000311 4.964603 
Within Groups 19382.01 10 1938.201    
       
Total 75449.78 11         
       
Tukeys Test       
       
M1 476.9574      
M2 250.3554      
Msw 19382.01      
n 6      
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Statistic= 3.986941      
critical value 4.91      
 
BAP (10uM)/5-MC 
(10uM)   
  
Mean 476.9574
Standard Error 7.076193
Median 482.885
Mode 481.86
Standard Deviation 64.85438
Sample Variance 4206.09
Kurtosis 0.198314
Skewness -0.3067
Range 294.46
Minimum 344.61
Maximum 639.07
Sum 40064.42
Count 84
Largest(1) 639.07
Smallest(1) 344.61
Confidence 
Level(95.0%) 14.07426
 
Chryene 10uM)/BAP 
(10uM)   
  
Mean 420.2751
Standard Error 9.1573
Median 398.6
Mode #N/A 
Standard Deviation 77.16079
Sample Variance 5953.787
Kurtosis 5.942661
Skewness 2.170431
Range 407.55
Minimum 335.28
Maximum 742.83
Sum 29839.53
Count 71
Largest(1) 742.83
Smallest(1) 335.28
Confidence Level(95.0%) 18.26366
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BAP (10uM)/5-MC 
(1uM)   
  
Mean 348.7192
Standard Error 4.159283
Median 344.725
Mode #N/A 
Standard Deviation 28.81636
Sample Variance 830.3824
Kurtosis 3.313031
Skewness 1.505429
Range 130.15
Minimum 313.83
Maximum 443.98
Sum 16738.52
Count 48
Largest(1) 443.98
Smallest(1) 313.83
Confidence 
Level(95.0%) 8.367397
 
5-MC (10uM)/BAP 
(1uM)   
  
Mean 347.237
Standard Error 4.13452
Median 343.425
Mode #N/A 
Standard Deviation 28.04168
Sample Variance 786.3359
Kurtosis -0.65609
Skewness 0.175493
Range 106.36
Minimum 295.5
Maximum 401.86
Sum 15972.9
Count 46
Largest(1) 401.86
Smallest(1) 295.5
Confidence 
Level(95.0%) 8.327351
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Chrysene (10uM)/BAP 
(1uM)   
  
Mean 419.9706
Standard Error 14.17117
Median 460.33
Mode #N/A 
Standard Deviation 97.15265
Sample Variance 9438.637
Kurtosis -1.87709
Skewness 0.067739
Range 252.61
Minimum 315.68
Maximum 568.29
Sum 19738.62
Count 47
Largest(1) 568.29
Smallest(1) 315.68
Confidence Level(95.0%) 28.52508
 
BAP (10uM) /Chrysene 
(1uM)   
  
Mean 309.2254
Standard Error 4.821829
Median 300.215
Mode #N/A 
Standard Deviation 34.09548
Sample Variance 1162.502
Kurtosis 2.351046
Skewness 1.477162
Range 152.08
Minimum 270.09
Maximum 422.17
Sum 15461.27
Count 50
Largest(1) 422.17
Smallest(1) 270.09
Confidence Level(95.0%) 9.689828
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Anova: Single 
Factor       
       
SUMMARY       
Groups Count Sum Average Variance   
Row 1 2 867.9878 433.9939 2343.699   
Row 2 2 732.2671 366.1336 300.6438   
Row 3 2 984.9206 492.4603 1252.348   
Row 4 2 786.9811 393.4905 3693.639   
Row 5 2 865.278 432.639 432.5206   
Row 6 2 702.314 351.157 648.7717   
Row 7 2 469.3907 234.6953 0   
       
       
ANOVA       
Source of Variation SS df MS F P-value F crit 
Between Groups 80738.76 6 13456.46 10.86247 0.003007 3.865969
Within Groups 8671.621 7 1238.803    
       
Total 89410.38 13         
       
Tukeys Test       
       
M1 393.4905      
M2 432.639      
Msw 1238.803      
n 2      
Statistic= 1.572999      
critical value 3.34      
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